<SEC-DOCUMENT>0001493152-24-013261.txt : 20240405
<SEC-HEADER>0001493152-24-013261.hdr.sgml : 20240405
<ACCEPTANCE-DATETIME>20240405091503
ACCESSION NUMBER:		0001493152-24-013261
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240405
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240405
DATE AS OF CHANGE:		20240405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		24824909

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:SMTI="http://sanaramedtech.com/20240405">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_SMTI_sanaramedtech.com_20240405 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240405_20240405 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:AmendmentFlag" id="ixv-469">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityCentralIndexKey" id="ixv-470">0000714256</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20240405.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-04-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-05</xbrli:startDate>
        <xbrli:endDate>2024-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">FORM
<span id="xdx_905_edei--DocumentType_c20240405__20240405_zTHSRTNJsCzd"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:DocumentType" id="ixv-490">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_905_edei--DocumentPeriodEndDate_c20240405__20240405_zGcm3LvLJdM1"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-491">April 5, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20240405__20240405_zn17N22Ur7bc"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityRegistrantName" id="ixv-492">SANARA
    MEDTECH INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20240405__20240405_zSIbns3z43qa"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-493">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20240405__20240405_zLtSxSCucHaf"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityFileNumber" id="ixv-494">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20240405__20240405_zKFvTcPdy2Qk"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityTaxIdentificationNumber" id="ixv-495">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <br/>
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <br/>
    File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer <br/>
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20240405__20240405_ztCHz1dTipLg"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityAddressAddressLine1" id="ixv-496">1200
                                            Summit Avenue</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20240405__20240405_zUyNF2SNWvt1"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityAddressAddressLine2" id="ixv-497">Suite 414</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressCityOrTown_c20240405__20240405_zTD9iqqeXE6e"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityAddressCityOrTown" id="ixv-498">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20240405__20240405_zVSbUFiuhrAf"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-499">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20240405__20240405_zWollLyRZbT9"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:EntityAddressPostalZipCode" id="ixv-500">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_90D_edei--CityAreaCode_c20240405__20240405_zaOxvgiunv8i"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:CityAreaCode" id="ixv-501">(817)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20240405__20240405_zVdVv5lQvs7l"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:LocalPhoneNumber" id="ixv-502">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)<b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span></p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--WrittenCommunications_c20240405__20240405_zWTMO0mYeTvl"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-503">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--SolicitingMaterial_c20240405__20240405_zaHKAkml7D9h"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-504">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20240405__20240405_z6FPJWsW0hGe"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-505">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20240405__20240405_zWIvumXTFzM6"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-506">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20240405__20240405_zwKeQa7DQlnk"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:Security12bTitle" id="ixv-507">Common
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20240405__20240405_zPB6VyECD1Ba"><ix:nonNumeric contextRef="AsOf2024-04-05" name="dei:TradingSymbol" id="ixv-508">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_90F_edei--SecurityExchangeName_c20240405__20240405_zyhpUvfsLET"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-509">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&#160;<span id="xdx_908_edei--EntityEmergingGrowthCompany_c20240405__20240405_z29YrCwPkZ4c"><ix:nonNumeric contextRef="AsOf2024-04-05" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-510">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    5.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
    of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
    </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Appointment
of Chief Operating Officer</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 5, 2024, Sanara MedTech Inc. (the &#8220;Company&#8221;) announced that the Board of Directors (the &#8220;Board&#8221;) of the
Company appointed Mr. Jacob A. Waldrop as the Chief Operating Officer of the Company, effective April 15, 2024 (the &#8220;Effective
Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Waldrop, age 42, has 20 years of experience leading cross functional teams through a multitude of business process transformations in
the technology and medical device industries. Prior to joining the Company, Mr. Waldrop served as the Vice President of Finance and Integrations
for the newly founded Foot and Ankle division of Enovis (formally DJO). Prior to Trilliant Surgical&#8217;s sale to Enovis in 2021, Mr.
Waldrop served as Chief Financial Officer for Trilliant Surgical. Prior to his employment at Trilliant Surgical, Mr. Waldrop held several
finance, management and controller positions with Alert Logic and The Planet. Mr. Waldrop began his career in public accounting with
KMPG in 2005. Mr. Waldrop earned a Bachelor of Science in Accounting and Management Information Systems from Texas A&amp;M University
and is a Texas certified public accountant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than the Employment Agreement (as defined below), there are no arrangements or understandings between Mr. Waldrop and any other persons
pursuant to which he was selected to serve as the Company&#8217;s Chief Operating Officer. There is no family relationship between Mr.
Waldrop and any director or executive officer of the Company. There are no transactions between Mr. Waldrop and the Company that would
be required to be reported under Item 404(a) of Regulation S-K of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with Mr. Waldrop&#8217;s appointment as Chief Operating Officer, the Company entered into an executive employment agreement
(the &#8220;Employment Agreement&#8221;), effective as of the Effective Date, pursuant to which Mr. Waldrop will serve as the Chief Operating
Officer of the Company for a two (2) year term with automatic successive one (1) year renewals, unless earlier terminated in accordance
with the terms of the Employment Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreement provides that&#8217;s Mr. Waldrop&#8217;s annual base salary will be $315,000, less applicable taxes and other legal
withholdings, which may be periodically adjusted at the discretion of the Compensation Committee of the Board. Further, Mr. Waldrop will
be eligible to receive an annual award of shares of restricted common stock equal to an amount of up to 75% of his base salary, subject
to approval of the Board. Mr. Waldrop will also be eligible to receive an annual cash bonus of up to 75% of his base salary based on
annual performance metrics during the term of his employment, subject to the approval of the Board, customary benefits and reimbursement
for reasonable business expenses, as well as other customary employment benefits including paid vacation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreement also provides that, within 30 days of the Effective Date, and subject to Board approval, Mr. Waldrop will be granted
a one-time restricted stock award of shares of common stock having a value equal to $100,000, based on the price of the Company&#8217;s
common stock on the Effective Date, with half of such shares vesting on each of the first two anniversaries of the Effective Date, provided
that Mr. Waldrop is employed by the Company through such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Employment Agreement, in the event that Mr. Waldrop&#8217;s employment is terminated by the Company without &#8220;cause&#8221;
(as defined in the Employment Agreement), by the Company or any successor entity within one (1) year of the effective date of a &#8220;change
of control&#8221; (as defined in the Employment Agreement) or due to Mr. Waldrop for &#8220;good reason&#8221; (as defined in the Employment
Agreement), Mr. Waldrop shall be entitled to receive a severance package which includes one year of base salary following the effective
date of termination, paid in 24 equal semi-monthly installments in accordance with the Company&#8217;s regular payroll practices, the
accelerated vesting of any stock grants granted prior to the effective date of termination and continued participation in any health
care benefits provided by the Company to its employees for the period of time during which severance payments are paid to Mr. Waldrop,
which continued participation in health care benefits may be through participation under the Consolidated Omnibus Budget Reconciliation
Act (&#8220;COBRA&#8221;) and reimbursement of COBRA premiums paid by Mr. Waldrop for such continued participation; provided that Mr.
Waldrop executes and delivers to the Company an executed release of claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreement also contains customary provisions relating to, among other things, confidentiality, non-competition, non-solicitation
and non-interference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the terms of the Employment Agreement is not complete and is qualified in its entirety by reference to the full
text of the Employment Agreement, a copy of which is filed with this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
    FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 5, 2024, the Company issued a press release announcing the appointment of Mr. Waldrop as the Company&#8217;s Chief Operating Officer.
A copy of the press release is attached hereto as Exhibit 99.1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221;
for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that section. Further, the information
in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the
filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof
and regardless of any general incorporation language in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Employment Agreement, effective April 15, 2024, by and between Sanara MedTech Inc. and Jacob A. Waldrop.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, dated April 5, 2024 (furnished pursuant to Item 7.01).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
April 5, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara
    MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Michael D. McNeil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
EMPLOYMENT AGREEMENT (this &ldquo;<B><I>Agreement</I></B>&rdquo;), executed to be effective as of April 15, 2024 (the &ldquo;<B><I>Effective
Date</I></B>&rdquo;), is entered into by and between <B>Sanara MedTech Inc.</B>, a Texas corporation (&ldquo;<B><I>Sanara</I></B>&rdquo;,
the &ldquo;<B><I>Company</I></B>&rdquo;, or the &ldquo;<B><I>Employer</I></B>&rdquo;), and <B>Jake Waldrop </B>(&ldquo;<B><I>Employee</I></B>&rdquo;).
The Employer and Employee may be referred to singularly as &ldquo;<B><I>Party</I></B>&rdquo; or collectively as &ldquo;<B><I>Parties</I></B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>WITNESSETH</U>:
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Employment Term</U></B>. Employee&rsquo;s employment and the initial term of this Agreement shall commence on the Effective Date
and continue for <B>twenty-four (24)</B> months, unless earlier terminated as provided in Section 5; <I>provided, however</I>, if not
earlier terminated, Employee&rsquo;s employment under this Agreement shall automatically renew or extend for consecutive terms of twelve
(12) months, unless either Party gives prior written notice to the other Party of its desire to terminate Employee&rsquo;s employment
under this Agreement at least thirty (30) days prior to the expiration of the initial term or any renewal term (collectively, the &ldquo;<B><I>Term</I></B>&rdquo;).
Termination of Employee&rsquo;s employment under this Agreement for any reason whatsoever by any Party shall have no effect on the continued
enforceability of Sections 4(f), 4(g), and 7 through 22 of this Agreement, which shall survive the expiration or termination of Employee&rsquo;s
employment under this Agreement, except as otherwise provided herein. Employee accepts such employment and agrees to perform the services
specified herein, all upon the terms and conditions hereinafter stated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Duties</U></B>. Employee shall serve in the position of Chief Operating Officer of the Company and will report to the Chief Executive
Officer of the Company. Employee further agrees to perform such other services for the Employer, and for any parent, subsidiary or affiliate
corporations of the Employer and any partnerships in which the Employer may from time to time have an interest (collectively, the &ldquo;<B><I>Affiliates</I></B>&rdquo;).
The term &ldquo;Employer&rdquo; as used in this Agreement shall be deemed to include and refer to all such Affiliates. During the Term,
Employee agrees to devote Employee&rsquo;s full time and energy and all of Employee&rsquo;s skill and best efforts to the performance
of Employee&rsquo;s job duties, as assigned by Employer, and to the business of Employer and shall perform such duties in a diligent,
trustworthy, and business-like manner in full compliance with all applicable laws. Employee shall not at any time during Employee&rsquo;s
employment with Employer: (a) work on any basis (including, without limitation, part-time or as an independent contractor) for a Competing
Business (as defined in Section 7); or (b) participate in any material way in any other business that is not a Competing Business to
the extent that such participation adversely affects Employee&rsquo;s performance of Employee&rsquo;s job duties for Employer in any
manner. Employee acknowledges and agrees that Employee will comply with Employer&rsquo;s existing and future policies, manuals and procedures
as adopted and provided to Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Compensation and Benefits</U></B>. As payment for the services to be rendered by Employee hereunder during the Term of this Agreement,
Employee shall be entitled to compensation and benefits as set forth in <U>Exhibit B</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Covenants of Employee</U></B>. For and in consideration of the employment herein contemplated and the consideration paid or promised
to be paid by the Employer, the opportunity to obtain grants of shares of common stock of Employer, Employer&rsquo;s giving Employee
access to Confidential Information during the Term as determined by Employer, Employee does hereby covenant, agree, and promise that
during the Term hereof and for a period thereafter to the extent specifically provided in this Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Employee will not actively engage, directly or indirectly, in any other business if such involvement would (i) interfere with his or
her duties as set forth herein, or (ii) violate the provisions of Section 7, Section 8 or Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Employee will not engage, directly or indirectly, in any activity that is directly competitive with the business of the Employer. This
prohibition shall include the ownership, management, operation, control of, employment by, participation in, in any manner, any business
of the type that is competitive with the business of Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Employee will truthfully and accurately make, maintain, and preserve all records and reports that the Employer may from time-to-time
request or require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Employee will fully account for all money, records, goods, wares, and merchandise, or other property belonging to the Employer of which
Employee has custody, and will promptly deliver the same whenever and however Employee may be reasonably directed to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Employee will obey all rules, regulations, and special instructions applicable to Employee, including but not limited to, those set forth
in the then existing Employee Policy Manual (as defined in <U>Exhibit B</U>) of the Employer, if any, and will be loyal and faithful
to the Employer at all times, constantly endeavoring to improve Employee&rsquo;s ability and knowledge of the business in an effort to
increase the value of Employee&rsquo;s services for the mutual benefit of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Employee agrees that upon the earlier of the request of Employer or termination of Employee&rsquo;s employment with Employer for any
reason, Employee will immediately surrender and turn over to the Employer all books, records, forms, specifications, formulae, data,
processes, papers and writings related to the business of the Employer and all other property belonging to the Employer, together with
all copies of the foregoing, it being understood and agreed that the same are the sole property of the Employer and that such Employer
property shall be returned to Employer without such property or any files or data thereon being deleted, altered or damaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Employee agrees that all ideas, concepts, processes, discoveries, devices, machines, tools, materials, designs, improvements, inventions,
and other things of value (collectively, &ldquo;<B><I>Intangible Rights</I></B>&rdquo;), whether patentable or not, which are conceived,
made, invented, or suggested either by Employee alone or in collaboration with others during the Term of Employee&rsquo;s employment
which pertain to the Business, and whether or not during regular working hours, shall be promptly disclosed in writing to the Employer
and shall be the sole and exclusive property of the Employer. Employee hereby assigns all of Employee&rsquo;s right, title, and interest
in and to all such Intangible Rights to the Employer, which Employer may then assign to Employer&rsquo;s successors or assignees. In
the event that any of said Intangible Rights are deemed by the Employer to be patentable or otherwise registerable under any federal,
state, or foreign law, Employee further agrees that, at the expense of Employer, Employee will execute all documents and do all things
necessary, advisable, or proper to obtain patents therefor or registration thereof, and to vest in the Employer full title thereto. The
Parties recognize that this Agreement does not require assignment of any materials (i) developed entirely on Employee&rsquo;s own time;
and (ii) developed without equipment, supplies, facility, trade secrets, or proprietary information of Employer or any of the Affiliates,
unless such Materials either: (a) relate at the time of conception or reduction to practice of the invention to any portion of the Business,
or actual or demonstrably anticipated research of development of Employer or any of the Affiliates; or (b) result from any work performed
by Employee for Employer or any of the Affiliates. All inventions and works of authorship, if any, patented or unpatented, registered
or unregistered, that Employee made prior to the Effective Date that are not owned by Employer are listed on an attachment hereto (hereafter
referred to as the &ldquo;<B><I>Prior Materials</I></B>&rdquo;). If no such list is attached, Employee represents that Employee does
not own or possess any Prior Materials. Employee shall not use any Prior Materials in any manner in connection with the Business. If
Employee incorporates Prior Materials owned by Employee, or in which Employee has an interest, into any work or services for the Employer
or any of the Affiliates, the Employer and the Affiliates are hereby granted and shall have a nonexclusive, royalty-free, fully paid-up,
irrevocable, perpetual, worldwide, sublicensable (directly or indirectly) license to make, have made, modify, use, sell, have sold, copy,
distribute, create derivative works, display, perform, and transmit such Prior Materials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Employee shall not, by reason of this Agreement, have any vested interest in, or right, title or claim to, any land, buildings, equipment,
machinery, processes, systems, products, contracts, goods, wares, merchandise, business assets, or other things of value belonging to
or which may hereafter be acquired, owned or leased from Employee by the Employer, without the prior written consent of Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Employee acknowledges that the nature of Employee&rsquo;s position with the Employer may mandate that Employee perform such duties and
render such services as are required of Employee hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Employee agrees that Employee will not disparage Employer or any of its officers, directors, or employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><U>Termination</U></B>. Employee&rsquo;s employment under this Agreement may be terminated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Termination by Employer for Cause</U>. The Employer may terminate the employment of Employee if Employee engages in any of the following
conduct (termination for &ldquo;<B><I>Cause</I></B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
breaching any material provision of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
misappropriating funds or property of the Employer or any of the Affiliates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
securing any personal profit not thoroughly disclosed to and approved by the Employer in connection with any transaction entered into
on behalf of the Employer or any of the Affiliates;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
engaging in conduct, even if not in connection with the performance of Employee&rsquo;s duties hereunder, which might be reasonably expected
to result in any effect materially adverse to the interests of the Employer or any of the Affiliates, such as fraud, dishonesty, indictment
or conviction for (or pleading <I>nolo contendere</I> to) any felony or a misdemeanor involving moral turpitude, or the indictment for
any felony or misdemeanor involving moral turpitude;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
failing to satisfactorily fulfill and perform Employee&rsquo;s duties in accordance with the terms hereof, except for any failure caused
by disability or death of Employee, as defined below; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
failing to comply with corporate policies of the Employer, including, but not limited to, those policies set forth in Section 20.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Termination by Employer without Cause</U>. The Employer may terminate Employee&rsquo;s employment under this Agreement without Cause
at any time upon written notice to Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Termination by Employer upon Death or Disability of Employee</U>. The Employer may terminate Employee&rsquo;s employment under this
Agreement upon the death or Disability of Employee. There shall be deemed to be &ldquo;<B><I>Disability</I></B>&rdquo; and Employee &ldquo;<B><I>Disabled</I></B>&rdquo;
for the purposes of this Agreement only if: (i) a medical doctor certifies that Employee has for ninety (90) consecutive or non-consecutive
days in any twelve (12) month period been disabled in a manner which has rendered Employee unable to perform the essential functions
of Employee&rsquo;s job duties, with or without reasonable accommodation; (ii) Employee is determined to be disabled under the terms
of any long-term disability plan in effect for Employer&rsquo;s employees at the applicable time; or (iii) Employee is determined to
be disabled by the U.S. Social Security Administration. Employee will cooperate in submitting to any requested medical examination for
the purpose of certifying disability under this Section 5(c) and will sign any documents needed to release the results of such medical
examination to the Employer or the Employer&rsquo;s designee for the purpose of any determination under this Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Termination by Employee for Convenience</U>. Employee shall have the right to terminate Employee&rsquo;s employment under this Agreement
at any time for any reason, or no reason at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Termination by Employee for Good Reason</U>. Employee shall have the right to terminate Employee&rsquo;s employment under this Agreement
at any time for Good Reason, subject to the cure rights set forth below. &ldquo;<B><I>Good Reason</I></B>&rdquo; shall mean the occurrence
of any of the following, in each case without Employee&rsquo;s consent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
A material reduction to Employee&rsquo;s Base Salary (as defined in <U>Exhibit B</U>);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
A material breach by the Employer of this Agreement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
A material, adverse change in Employee&rsquo;s title or authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, none of the occurrences outlined in clauses (i)-(iii) above shall constitute Good Reason for Employee&rsquo;s resignation
from employment unless the following conditions are satisfied: (1) Employee provides the Board written notice of such occurrence, with
such notice specifying the date and amount of any reduction, how the Agreement was materially breached, or the material adverse change
in title or authority, as applicable, and the obligation to cure within sixty (60) days of the initial existence of such reduction, breach,
or change; (2) Employer fails to cure such reduction, breach, or change within forty-five (45) days from the date the written notice
from Employee is delivered to the Board; and (3) Employee&rsquo;s resignation for Good Reason must be effective no later than one-hundred
and ten (110) days after the initial reduction, breach, or change that is the basis for the Good Reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notice of Termination</U>. Any termination of Employee&rsquo;s employment under this Agreement pursuant to Section 1 or this Section
5 (other than pursuant to Section 5(c) on account of Employee&rsquo;s death) shall be communicated by written notice of termination (each,
a &ldquo;<B><I>Notice of Termination</I></B>&rdquo;) to the other Party in the manner provided in Section 10. The Notice of Termination
shall specify: (i) the termination provision of this Agreement relied upon; and (ii) the applicable date of termination. Any termination
under Section 5(d) or 5(e) shall require Employee to provide a minimum of ninety (90) days&rsquo; notice to Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B><U>Payment upon Termination</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In the event Employee&rsquo;s employment under this Agreement is terminated by (i) Employer without Cause, (ii) Employer or any successor
entity within one (1) year of the effective date of a Change of Control (as hereinafter defined), or (iii) Employee for Good Reason,
Employee shall be entitled to receive a severance package which will include <B>one (1) year </B>of Base Salary (as defined in <U>Exhibit
B</U>) following the effective date of termination, paid in <B>twenty-four (24)</B> equal semi-monthly installments in accordance with
the Employer&rsquo;s regular payroll practices, the accelerated vesting of any stock grants granted prior to the effective date of termination,
and continued participation in any health care benefits provided by the Employer to its employees for the period of time during which
severance payments are paid to Employee, which continued participation in health care benefits may be through participation under the
Consolidated Omnibus Budget Reconciliation Act (&ldquo;<B><I>COBRA</I></B>&rdquo;) and reimbursement of COBRA premiums paid by Employee
for such continued participation; provided Employee executes and delivers to Employer a release in substantially the form attached hereto
as <U>Exhibit A</U> and in accordance with the terms of such release. Any and all amounts received by Employee pursuant to this Section
6(b) shall constitute the full and total amount of liquidated damages that Employee shall be entitled to receive from the Employer and
its Affiliates, and Employee releases any and all other contract or tort claims arising out of Employee&rsquo;s employment relationship
with the Employer or any relationship with any of the Affiliates. Notwithstanding the foregoing, in the event the time period for Employee
to return a validly executed, irrevocable release described in this Section 6(b) spans two taxable years, the salary continuation payments
described in this section shall not commence until the second taxable year, with the first such payment including any amounts that would
have been paid to Employee prior to such time but for this provision of Section 6(b). For the purposes of this Agreement, a &ldquo;Change
of Control&rdquo; shall be deemed to occur upon the happening of any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    there occurs a change in the composition of the Board of Directors of Company as a result of which fewer than a majority of the directors
    are the same directors constituting such board as of the Effective Date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    is party to a merger or consolidation, or series of related transactions, which results in the outstanding shares of Company immediately
    prior thereto failing to continue to represent (either by remaining outstanding or by being converted into voting securities of the
    surviving or another entity) Fifty percent (50%) or more of the combined voting power of the voting securities of the Company or
    such surviving or other entity outstanding immediately after such merger or consolidation.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    sale or disposition of all or substantially all of the Company&rsquo;s assets (or consummation of any transaction, or series of related
    transactions, having similar effect).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In the event Employee&rsquo;s employment under this Agreement is terminated by Employer due to Employee&rsquo;s death or Disability,
Employee or Employee&rsquo;s estate shall be entitled to receive Employee&rsquo;s Base Salary (as defined in <U>Exhibit B</U>) earned
and accrued through the effective date of termination (including any vested common stock granted to Employee), plus reimbursement for
any approved expenses incurred but unpaid as of such date in accordance with <U>Exhibit B</U>, Section 2, all of which shall constitute
the full and total amount of liquidated damages that Employee shall be entitled to receive from the Employer and its Affiliates, and
Employee releases any and all other contract or tort claims arising out of Employee&rsquo;s employment relationship with the Employer
any relationship with any of the Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
All amounts due and owing to either Employee or Employer under this Agreement shall be subject to offset to the extent permitted by law
by the amount of actual damages, if any, caused to either Party by any breach of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>Covenant Not to Compete</U></B>. Employee recognizes that the Employer has business goodwill and other legitimate business interests
which must be protected in connection with and in addition to the &ldquo;Confidential Information&rdquo; as defined in Section 9 below,
and therefore, in exchange for access to the Confidential Information and the opportunity to obtain shares of common stock of the Company,
Employee agrees and covenants that during Employee&rsquo;s employment or any other engagement with Employer and for twelve (12) months
thereafter, no matter the reason for any termination of employment or engagement (the &ldquo;<B><I>Restricted Period</I></B>&rdquo;),
subject to the provisions contained hereinbelow, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Agreement Not to Compete</U>. Employee will not, either directly or indirectly, (a) for Employee, or (b) as a shareholder, owner,
partner, joint venturer, promoter, consultant, manager, independent contractor, agent, employee or in any other capacity, participate
in or provide services to a Competing Business (as defined below) within the Territory (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Agreement Not to Solicit Customers</U>. Employee will not, either directly or indirectly, on Employee&rsquo;s own behalf or in the
service of or on behalf of any other person or entity, solicit or attempt to divert to a Competing Business or to any third party any
person, concern, or entity who is or was, or in the future will be (at the time of solicitation), a Customer of Employer or any of the
Affiliates whether within or without the Territory. Further, Employee will not, either directly or indirectly, on Employee&rsquo;s own
behalf or in the service of or on behalf of any other person or entity, initiate a call upon any person or entity who is, or was, or
in the future will be (at the time of solicitation), a Customer of Employer or any of the Affiliates for the purpose of diverting or
appropriating business to a Competing Business or to any third party, and further, if any such Customer initiates a call upon Employee,
then Employee shall not entertain any such call without first receiving approval from the Employer. Employee agrees that, among other
actions, any notification, update or other communication to any such Customer of Employee&rsquo;s relationship or status with any Competing
Business &ndash; whether such notification or update is through LinkedIn, Facebook, any other social media outlet, email, letter or by
any other method &ndash; constitutes a solicitation of business and an attempt to transact business with such Customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Agreement Not to Solicit Employees</U>. Employee will not, either directly or indirectly, on Employee&rsquo;s own behalf or in the
service of or on behalf of any other person or entity, hire, solicit, divert, or recruit any employee or contractor of Employer or any
of the Affiliates with whom Employee had contact during Employee&rsquo;s employment with Employer or any former contractor or employee
of Employer or any of the Affiliates with whom Employee had contact during Employee&rsquo;s employment with Employer, unless such former
contractor or former employee&rsquo;s relationship with the Employer or any of the Affiliates (looking at the date of the last relationship
between Employee and either Employer or any of the Affiliates) has been terminated for at least twelve (12) months as of the date of
such hiring, solicitation, diversion or recruitment, to leave such employment or engagement or otherwise terminate his or her employment
or engagement, whether or not such employment or engagement is pursuant to a written contract or at-will, or become hired or engaged
by any other person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Non-Interference</U>. Employee will not induce or solicit or attempt to induce or solicit or cause, in any way, any actual or prospective
Customer of Employer or any of the Affiliates or assist any other person or entity in inducing or soliciting or attempting to induce
or solicit or causing, in any way, any such person or entity to discontinue or decrease its respective relationship with Employer or
any of the Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Business
</I></B>means providing, selling, developing or manufacturing wound and/or skin care and/or soft tissue repair related products of the
type or nature of, or competitive with, those provided, sold or manufactured by Employer or any of the Affiliates, including, without
limitation, providing virtual consultation and/or clinician services to patients using Employer&rsquo;s or any of the Affiliates&rsquo;
products and any other line of business in which Employer or any of the Affiliates become involved or takes steps to become involved
during Employee&rsquo;s employment or engagement with Employer or any of the Affiliates, provided that Employee has knowledge of Employer
or any of the Affiliates becoming involved in such other line of business or any of the steps taken by Employer or any of the Affiliates
to become involved in such other line of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Competing
Business</I></B> means any person, concern or entity which is engaged in, or preparing to engage in, the Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Customer
</I></B>means a person or entity which sells to, and/or buys Employer&rsquo;s, or any of the Affiliates&rsquo; products or services and
with whom or which Employee had contact during Employee&rsquo;s employment or engagement with Employer or any of the Affiliates or about
which or whom Employee received Confidential Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Territory
</I></B>means the United States and any additional countries in which the Employer engages in business in any material manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Acknowledgment of Enforceability</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Employee expressly acknowledges and agrees that Employee&rsquo;s experience and abilities are such that Employee&rsquo;s observance of
the covenants and restrictive agreements contained herein are reasonable as to scope, location and duration and that such observation
shall not cause Employee any undue hardship or unreasonably interfere with Employee&rsquo;s ability to earn a livelihood. Employee has
been provided with an opportunity to consult with legal counsel of Employee&rsquo;s selection for the meaning of the covenants and restrictions,
which have been explained to Employee&rsquo;s satisfaction. Employee hereby agrees that the limitations set forth above are reasonable
and necessary for the protection of the Business and the Employer and the Affiliates. In this regard, Employee specifically agrees that
such limitations as to the period of time, geographic area and types and scope of restrictions on Employee&rsquo;s activities are reasonable
and necessary to protect the goodwill, Confidential Information, and other business interests of the Business and the Employer and the
Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Notwithstanding anything contained in this Section 7 to the contrary, Employee shall not be prohibited from working for an entity with
a division or subsidiary that competes with the Business and/or the Employer or any of the Affiliates provided: (x) Employee is not directly
involved in the provision of services to such division or subsidiary; and (y) such division or subsidiary does not comprise more than
ten percent (10%) of the total business activities of the overall entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Revision</U>. It is mutually understood and agreed that if any of the provisions relating to the scope, time, or Territory of this
Agreement are more extensive than is enforceable under applicable law, then the Parties agree that a Court shall reduce the degree and
extent of such provisions by whatever minimal amount is necessary to bring such provisions within the ambit of enforceability under applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Remedies</U>. The invalidity or non-enforceability of this Section 7 in any respect shall not affect the validity or enforceability
of any other provisions of this Agreement. The Parties agree that the limitations contained in this Section 7 with respect to time, geographical
area and scope of activity are reasonable. Employer&rsquo;s and the Affiliates&rsquo; remedies at law for any breach or threatened breach
of the provisions of this Section 7 may be insufficient and may be inadequate, and Employer and the Affiliates shall be entitled to equitable
relief, including by way of temporary and permanent injunction, without any requirement to post bond or other security therefor, in addition
to any remedies Employer or any of the Affiliates may have at law. The existence of any claim or cause of action by Employee against
Employer or any of the Affiliates, whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement
by Employer, or any of the Affiliates, of Sections 7 and 9 of this Agreement. If Employee (i) breaches any restriction in Sections 7
or 9, or (ii) if Employee or anyone acting on Employee&rsquo;s behalf brings a claim against Employer or any of the Affiliates seeking
to declare any term in Section 7 or 9 void or unenforceable, Employer or any of the Affiliates shall be entitled to: (A) damages incurred
by Employer or any of the Affiliates as a result of any breach; and (B) recover their attorneys&rsquo; fees, witness fees, and costs
incurred in such actions, in addition to any other remedies. If Employee is found by a court of competent jurisdiction to have violated
any of the restrictions contained in Section 7, the Restricted Period will be deemed to be extended for a period of time equivalent to
the time Employee was in violation of any of the restrictions in Section 7 and will not run in favor of Employee until such time that
Employee cures the violation to the reasonable satisfaction of Employer. If Employee during the Restricted Period seeks or is offered
employment or any other position with a Competing Business, Employee agrees to inform the Competing Business, before accepting employment
or any other position, of the existence of the restrictions in Sections 7 and 9. Further, before taking any employment or other position
with any Competing Business during the Restricted Period, Employee agrees to give prior written notice to the Employer of the name of
such Competing Business and the job title, location and responsibilities of the position that Employee plans to accept. Employer shall
be entitled to advise such Competing Business of the provisions of Sections 7 and 9 and to otherwise deal with such Competing Business
to ensure that the provisions of Sections 7 and 9 are enforced and duly discharged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<B><U>Business Opportunities</U></B>. For as long as Employee shall be employed or engaged by the Employer or any of the Affiliates and
thereafter with respect to any business opportunities learned about during the time of Employee&rsquo;s employment or engagement by the
Employer or any of the Affiliates, Employee agrees that with respect to any future business opportunity or other new and future business
proposal which is offered to, or comes to the attention of, Employee during the Term of this Agreement or any renewal term thereof, and
which is specifically related to, or connected with, the Business, the Employer shall have the right to take advantage of such business
opportunity or other business proposal for its own benefit. Employee may not take advantage of such opportunity regardless of whether
the Employer elects to exercise its right to take advantage of such opportunity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B><U>Confidential Information</U></B>. Employee acknowledges that in the course of Employee&rsquo;s employment with the Employer, Employee
will receive access to certain trade secrets and Confidential Information. For purposes of this Agreement, &ldquo;<B><I>Confidential
Information</I></B>&rdquo; includes trade secrets or confidential information of Employer or concerning any of the Affiliates, including,
without limitation: current and/or prospective client, referral source, business partner, investor, supplier, distributor, contractor,
merchant and/or vendor lists, databases, identity, contact, preferences, purchasing patterns, pricing policies, upcoming needs, and/or
other information and/or history; contracts; information concerning employee skills or other employee information that a competitor may
find valuable; processes; technical data or processes; policies; pricing, costs, marketing, sales, profits, business, marketing and/or
other strategies, plans, analysis, studies, know-how, practices or information; designs; testing results; business and/or training manuals;
business and/or financial information; audit processes; management methods and/or information; proprietary computer programs, information
processing standards and practices; any original works of authorship by Employer; any similar information concerning any of the Affiliates,
whether received prior to or after the Effective Date; or other business information disclosed to Employee by the Employer or any of
the Affiliates, either directly or indirectly, in writing, orally, or by drawings or observation. Employee understands and agrees that
Employer is not required to provide Employee with all of the types of Confidential Information listed in the preceding sentence, but
that Employer will provide Employee with access to some of these types of Confidential Information in a manner and at a time in Employer&rsquo;s
sole discretion. In exchange for Employer&rsquo;s promise to provide Employee with Confidential Information &ndash; regardless of whether
the Confidential Information at issue was provided before or after the Effective Date &ndash; Employee shall not, during the period of
Employee&rsquo;s employment or engagement with Employer or any of the Affiliates or at any time thereafter, take, disclose, publish,
use, exploit, or solicit, allow or assist another person to use, take, disclose, publish or exploit any Confidential Information, except
as: (a) required in the ordinary course of Employer&rsquo;s business directly related to Employee&rsquo;s employment with Employer and
for the benefit of Employer; or (b) as required by law. Employee further represents Employee will not, and acknowledges that Employer
has specifically instructed Employee not to, disclose to Employer or any of the Affiliates, use, or induce Employer or any of the Affiliates
to use any confidential or proprietary information or material belonging to any third party. Additionally, during Employee&rsquo;s employment,
Employer or Employee may receive from third parties their confidential information. Employee agrees not to take, use, publish, exploit
or disclose any third party&rsquo;s confidential information to any person or organization except as necessary in the course of Employee&rsquo;s
employment with Employer and in accordance with any use agreement between the Employer and such third party. Furthermore, upon the earlier
of the request by Employer or upon the termination of Employee&rsquo;s employment with Employer for any reason, Employee shall immediately
return and deliver to Employer any and all Confidential Information and all other Employer or any Affiliates documents and items &ndash;
whether in hard or digital form &ndash; and all copies thereof which belong to Employer or any of the Affiliates or relate to Employer&rsquo;s,
or any of the Affiliates&rsquo; business and which are in Employee&rsquo;s possession, custody or control, whether prepared by Employee
or others, without altering such documents or items before providing them to Employer, including, without limitation, by not deleting
any files or other information from any Employer laptop or other device before providing the item to Employer. Employee further agrees
that, after Employee provides a copy of such information or documents to Employer, Employee will: (a) immediately delete and write over
any information or documents relating to Employer&rsquo;s or any Affiliates&rsquo; business from any computer, cellular phone or other
digital or electronic device owned by Employee; and (b) execute a termination certificate, certifying the return of all Confidential
Information and the deletion of all such information from any digital or electronic device owned by Employee and provide such certificate
to Employer. Notwithstanding any other provision of this Agreement: (i) Employee may disclose Confidential Information when required
to do so by a court of competent jurisdiction, by any governmental agency having authority over Employee or the business of Employer
or by any administrative body or legislative body (including a committee thereof) with jurisdiction to order Employer to divulge, disclose
or make accessible such information; and (ii) nothing in this Agreement is intended to interfere with Employee&rsquo;s right to (A) report
possible violations of state or federal law or regulation to any governmental or law enforcement agency or entity; (B) make other disclosures
that are protected under the whistleblower provisions of state or federal law or regulation; (C) file a claim or charge with the Equal
Employment Opportunity Commission (&ldquo;<B><I>EEOC</I></B>&rdquo;), any state human rights commission, or any other governmental agency
or entity; or (D) testify, assist, or participate in an investigation, hearing, or proceeding conducted by the EEOC, any state human
rights commission, any other governmental or law enforcement agency or entity, or any court. For purposes of clarity, in making or initiating
any such reports or disclosures or engaging in any of the conduct outlined in subsection (ii) above, Employee may disclose Confidential
Information to the extent necessary to such governmental or law enforcement agency or entity or such court, need not seek prior authorization
from Employer, and is not required to notify Employer of any such reports, disclosures or conduct. Employee is also hereby notified in
accordance with the Defend Trade Secrets Act of 2016 that Employee will not be held criminally or civilly liable under any federal or
state trade secret law for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official,
either directly or indirectly, or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or
is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If Employee files a lawsuit for retaliation
against Employer or any of the Affiliates for reporting a suspected violation of law, Employee may disclose Employer&rsquo;s and any
Affiliates&rsquo; trade secrets to Employee&rsquo;s attorney and use the trade secret information in the court proceeding if Employee
files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order. Also,
nothing in this Section 9 shall interfere with any rights that exist under the National Labor Relations Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<B><U>Notices</U></B>. All notices, requests, consents, demands, or other communications required or permitted to be given pursuant to
this Agreement shall be deemed sufficiently given when delivered either (i) personally with a written receipt acknowledging delivery,
or (ii) within three (3) business days after the posting thereof by United States first class, registered or certified mail, return receipt
requested, with postage fee prepaid and addressed to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Employer: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
    MedTech Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    <B>Zachary Fleming</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
    Executive Officer</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1200
    Summit Ave, Suite 414</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fort
    Worth, Texas 76102</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to Employee: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jake
    Waldrop</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
Party, at any time, may designate additional or different addresses for subsequent notices or communication by furnishing notice to the
other Party in the manner described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<B><U>Severability</U></B>. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Agreement shall be prohibited by or invalid under applicable law, such provisions
shall be ineffective to the extent of such provision or invalidity only and shall be reformed as described in Section 7 if relating to
Section 7, without invalidating the remainder of such provision or any remaining provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<B><U>Assignment</U></B>. This Agreement may not be assigned by Employee. Neither Employee, Employee&rsquo;s spouse, nor their estates
shall have any right to encumber or dispose of any right to receive payments under this Agreement, it being understood that such payments
and the right thereto are non-assignable and nontransferable. Employer may assign this Agreement. Additionally, the Parties agree that
the Affiliates are third party beneficiaries under this Agreement and may enforce Sections 7, 8 and 9 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<B><U>Binding Effect</U></B>. Subject to the provisions of Section 12 above, this Agreement shall be binding upon and inure to the benefit
of the Parties hereto, Employee&rsquo;s heirs and personal representatives, and the successors and assignees of the Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<B><U>Prior Employment Agreements</U></B>. Employee represents and warrants to the Employer that Employee has fulfilled all of the terms
and conditions of all prior employment agreements to which Employee may be a party or have been a party and that at the time of execution
of this Agreement, Employee represents and warrants that nothing contained in any agreement that Employee has with any third party shall
preclude Employee from performing all of Employee&rsquo;s duties, obligations and covenants as contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<B><U>Waiver</U></B>. Any waiver to be enforceable must be in writing and executed by the Party against whom the waiver is sought to
be enforced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<B><U>Governing Law; Arbitration</U></B>. This Agreement shall be construed and enforced in accordance with and governed by the laws
of the state of Texas without regard to conflict of laws rules thereof or of any other jurisdiction. Each Party agrees that upon the
written demand of the other Party, whether made before or after the institution of any legal proceedings, but prior to the rendering
of any judgment in that proceeding, all disputes, claims and controversies between them, whether individual, joint, or class in nature,
arising from this Agreement, or any document, instrument, or agreement executed in connection herewith, including without limitation
contract disputes and tort claims, shall be resolved by binding arbitration pursuant to the Arbitration Rules of the American Arbitration
Association (&ldquo;<B><I>AAA</I></B>&rdquo;). The arbitration shall be conducted by one (I) arbitrator who shall be selected using a
listing process whereby the AAA administrator shall provide each party with a list of proposed arbitrators who are generally familiar
with the underlying subject matter made the basis of the dispute. Thereafter, each Party shall be given ten (10) days to strike any unacceptable
names from the list and number the remaining names in order of mutual preference. The arbitration shall be conducted in Tarrant County,
Texas. The language of the arbitration shall be in English. This arbitration provision shall not limit the right of either Party during
any dispute, claim or controversy to seek, use, and employ ancillary, or preliminary rights and/or remedies, judicial or otherwise, for
the purposes of realizing upon, preserving, or protecting any rights of either Party, and any such action shall not be deemed an election
of remedies. Such remedies include, without limitation, obtaining injunctive relief or a temporary restraining order, obtaining a writ
of attachment or imposition of a receivership, or exercising any rights relating to personal property, in which event, the Party seeking
such equitable relief can file an action in court notwithstanding this arbitration provision. Any disputes, claims or controversies concerning
the lawfulness or reasonableness of an act, or exercise of any right or remedy, including any claim to rescind, reform, or otherwise
modify this Agreement, shall also be arbitrated: <I>provided, however,</I> that no arbitrator shall have the right or the power to enjoin
or restrain any act of either Party. It is understood and agreed that the arbitrator shall have no authority to award punitive or other
damages not measured by the prevailing Party&rsquo;s actual damages, except as may be required by statute. Judgment upon any award rendered
by any arbitrator may be entered in any court having jurisdiction. The statute of limitations, estoppel, waiver, laches and similar doctrines
which would otherwise be applicable in an action brought by a Party shall be applicable in any arbitration proceeding, and the commencement
of an arbitration proceeding shall be deemed the commencement of any action for these purposes. The Federal Arbitration Act (Title 9
of the United States Code) shall apply to the construction, interpretation, and enforcement of this arbitration provision. Each Party
shall bear its own costs and expenses and an equal share of the arbitrator&rsquo;s and administrative fees of arbitration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<B><U>Attorneys&rsquo; Fees</U></B>. If any litigation is instituted to enforce or interpret the provisions of this Agreement, the prevailing
Party in such action shall be entitled to recover its reasonable attorneys&rsquo; fees from the other Party or Parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<B><U>Drafting</U></B>. Each of the Parties hereto acknowledges that each Party was actively involved in the negotiation and drafting
of this Agreement and that no law or rule of construction shall be raised or used in which the provisions of this Agreement shall be
construed in favor or against any Party hereto because one is deemed to be the author thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<B><U>Multiple Counterparts</U></B>. This Agreement may be executed in multiple counterparts, each of which shall have the force and
effect of an original, and all of which shall constitute one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<B><U>Conflicts of Interest</U></B>. It is the express policy of the Employer to conduct its affairs in strict compliance with the letter
and spirit of the law and to adhere to the highest principles of business ethics. Accordingly, all officers, employees (including Employee)
and independent contractors must avoid activities that are in conflict, or give the appearance of being in conflict, with these principles
and with the interests of the Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are potentially compromising situations that must be avoided. Any exceptions must be reported to the Chief Executive Officer
of Employer and written approval for continuation of such actions must be obtained from the Chief Executive Officer of Employer before
any such actions may continue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Revealing or misusing confidential information to outsiders. Unauthorized divulging of information is a violation of this policy whether
or not for personal gain and whether or not harm to the Employer is intended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Accepting or offering substantial gifts, excessive entertainment, favors, or payments which may be deemed to constitute undue influence
or otherwise be improper or embarrassing to the Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Accepting or offering consulting or freelance employment for any outside firm or entity, unless otherwise set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Initiating or approving any form of sexual or other harassment, retaliation, or discrimination concerning employees of the Employer or
any of the Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Investing or holding outside directorships in suppliers, customers, or any Competing Business, including financial speculation, where
such investment or directorship might influence in any manner a decision or course of action by the Employer; <I>provided, however</I>,
that Employee may own up to five percent (5%) of a publicly traded company that engages in a Competing Business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Borrowing from or lending to employees, customers, or suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Improperly using or disclosing to the Employer any proprietary information or trade secrets of any former or concurrent employer or other
person or entity with whom obligations of confidentiality exist.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Unlawfully discussing prices, costs, customers, sales, or markets with any Competing Business or its employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Making unlawful agreements with competitors with respect to prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Engaging in any conduct which is not in the best interest of the Employer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<B><U>COUNSEL</U></B>. EMPLOYEE ACKNOWLEDGES THAT EMPLOYEE IS EXECUTING A LEGAL DOCUMENT THAT CONTAINS CERTAIN DUTIES, OBLIGATIONS AND
RESTRICTIONS AS SPECIFIED HEREIN. EMPLOYEE FURTHERMORE ACKNOWLEDGES THAT EMPLOYEE HAS BEEN ADVISED OF EMPLOYEE&rsquo;S RIGHT TO RETAIN
LEGAL COUNSEL, AND THAT EMPLOYEE HAS EITHER BEEN REPRESENTED BY LEGAL COUNSEL PRIOR TO EMPLOYEE&rsquo;S EXECUTION HEREOF OR HAS KNOWINGLY
ELECTED NOT TO BE SO REPRESENTED.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<B><U>Section 409A</U></B>. This Agreement is intended to be interpreted and applied so that the payments and benefits set forth herein
shall either be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and
other authoritative guidance issued thereunder (&ldquo;<B><I>Section 409A</I></B>&rdquo;), or shall comply with the requirements of Section
409A. In no event may Employee, directly or indirectly, designate the calendar year of any payment to be made under this Agreement or
otherwise which constitutes a &ldquo;deferral of compensation&rdquo; within the meaning of Section 409A. Notwithstanding anything in
this Agreement or elsewhere to the contrary, a termination of employment shall not be deemed to have occurred for purposes of any provision
of this Agreement providing for the payment of any amounts or benefits that constitute &ldquo;non-qualified deferred compensation&rdquo;
within the meaning of Section 409A upon or following a termination of Employee&rsquo;s employment unless such termination is also a &ldquo;separation
from service&rdquo; within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a &ldquo;termination,&rdquo;
&ldquo;termination of employment&rdquo; or like terms shall mean &ldquo;separation from service&rdquo; within the meaning of Section
409A. For purposes of Section 409A, each payment under this Agreement to Employee (including any installment payments) shall be deemed
a separate payment. With respect to any expense reimbursement provided pursuant to this Agreement (i) the expenses eligible for reimbursement
must be incurred during the term of employment, (ii) the amount of expenses eligible for reimbursement during any calendar year will
not affect the amount of expenses eligible for reimbursement in any other calendar year, (iii) the reimbursements for expenses for which
Employee is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which
the applicable expense is incurred, and (iv) the right to payment or reimbursement hereunder may not be liquidated or exchanged for any
other benefit. Notwithstanding any provision in this Agreement or elsewhere to the contrary, if on Employee&rsquo;s termination of employment,
Employee is deemed to be a &ldquo;specified employee&rdquo; within the meaning of Section 409A, any payments or benefits due upon a termination
of Employee&rsquo;s employment under any arrangement that constitutes a &ldquo;deferral of compensation&rdquo; within the meaning of
Section 409A (whether under this Agreement, any other plan, program, payroll practice or any equity grant) and which do not otherwise
qualify under the exemptions under Treasury Regulation section 1.409A-1 (including without limitation, the short-term deferral exemption
and the permitted payments under Treasury Regulation section 1.409A-1(b)(9)(iii)(separation pay plan exemption), shall be delayed and
paid or provided to Employee in a lump sum (whether they would have otherwise been payable in a single sum or in installments in the
absence of such delay) on the earlier of (x) the date which is six (6) months and one (1) day after Employee&rsquo;s separation from
service for any reason other than death, and (y) the date of Employee&rsquo;s death, and any remaining payments and benefits shall be
paid or provided in accordance with the normal payment dates specified for such payment or benefit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, Employee acknowledges that Employee has received, read, and agrees to adhere to the terms and conditions contained within
this Agreement, including, without limitation, for confidentiality and noncompetition and non-solicitation requirements, assignment of
inventions, and conflict of interest guidelines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Signature
Page Follows]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Parties hereto have executed this Agreement as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
    EMPLOYER</B>: </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SANARA
    MEDTECH INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYEE</B>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jake Waldrop </I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jake
    Waldrop </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF RELEASE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this General Release, the term &ldquo;claims&rdquo; shall include all claims, covenants, warranties, promises, undertakings,
actions, suits, causes of action, obligations, debts, attorneys&rsquo; fees, accounts, judgments, losses and liabilities, of whatsoever
kind or nature, in law, equity or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
and in consideration of the payments described in <U>Exhibit B</U> to the Employment Agreement, and other good and valuable consideration,
you, for and on behalf of yourself and your heirs, administrators, executors, and assigns, effective as of the Effective Date (as defined
herein below), do fully and forever release, remise and discharge Employer, its direct and indirect parents, subsidiaries and affiliates,
together with their respective officers, directors, partners, shareholders, members, managers, employees and agents (collectively, the
&ldquo;<B><I>Group</I></B>&rdquo;) from any and all claims which you had, may have had, or now have against Employer or any other member
of the Group, for or by reason of your employment or the termination of your employment with Employer, including but not limited to claims
of breach of contract, wrongful termination, unjust dismissal, defamation, libel or slander, or under any federal, state or local law
dealing with discrimination based on age, race, sex, national origin, handicap, religion, disability or sexual preference. This release
of claims includes, but is not limited to, all claims arising under the Age Discrimination in Employment Act, Title VII of the Civil
Rights Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Equal Pay Act, and all other federal, state and local
labor and anti- discrimination laws, the common law and any other purported restriction on an employer&rsquo;s right to terminate the
employment of employees. You specifically release all claims under the Age Discrimination in Employment Act (the &ldquo;<B><I>ADEA</I></B>&rdquo;)
relating to your employment and its termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
represent that you have not filed or permitted to be filed against the Group, individually or collectively, any charges, complaints or
lawsuits arising out of your employment with Employer and the termination thereof and you covenant and agree that you will not file or
permit to be filed any lawsuits at any time hereafter with respect to the subject matter of this General Release and claims released
pursuant to this General Release (including, without limitation, any claims relating to the termination of your employment), except as
may be necessary to enforce this General Release or to seek a determination of the validity of the waiver of your rights under the ADEA.
Nothing in this General Release shall be construed to prohibit you from filing a charge with or participating in any investigation or
proceeding conducted by the Equal Employment Opportunity Commission (&ldquo;<B><I>EEOC</I></B>&rdquo;) or a comparable state or local
agency. Notwithstanding the foregoing, you agree to waive your right to recover monetary damages in any charge, complaint, or lawsuit
filed by you or by anyone else on your behalf. Except as otherwise provided in this paragraph, you will not voluntarily participate in
any judicial proceeding of any nature or description against any member of the Group that in any way involves the allegations and facts
that you could have raised against any member of the Group as of the date you sign this General Release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
right to receive the Severance Payments set forth in <U>Exhibit B</U> to the Employment Agreement is expressly conditioned upon your
executing and delivering to the Employer, within <B>______</B> days of the employment termination date, this General Release and the
expiration of the revocation period described herein without any portion of this General Release having been revoked.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are specifically agreeing to the terms of this release because Employer has agreed to pay you money and other benefits to which you were
not otherwise entitled and has provided such other good and valuable consideration as specified herein. Employer has agreed to provide
this money and other benefits because of your agreement to accept it in full settlement of all possible claims you might have or ever
had, and because of your execution of this General Release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
terms capitalized herein but not otherwise defined shall have the meaning given to them in the Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
acknowledge that you have read this General Release in its entirety, fully understand its meaning and are executing this General Release
voluntarily and of your own free will with full knowledge of its significance. You acknowledge and warrant that you have had the opportunity
to consider for <B>______ (___)</B> days the terms and provisions of this General Release and that you have been advised by Employer
to consult with an attorney prior to executing this General Release. You may execute this General Release prior to the conclusion of
the <B>__________ (___) </B>day period, and if you elect to do so, you acknowledge that you have done so voluntarily. You shall have
the right to revoke this General Release for a period of seven (7) days following your execution of this General Release, by giving written
notice of such revocation to Employer in accordance with Section 10 of the Employment Agreement. This General Release shall not become
effective until the eighth (8<SUP>th</SUP>) day following your execution of it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPENSATION
AND BENEFITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Compensation</U></B>. As payment for the services to be rendered by Employee hereunder during the Term of this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Employee shall be entitled to receive an annual base salary in the gross amount of <B>Three Hundred Fifteen Thousand and No/100 Dollars
($315,000.00)</B> less applicable taxes and other legal withholdings (the &ldquo;<B><I>Base Salary</I></B>&rdquo;), payable in accordance
with the Employer&rsquo;s standard payroll practice. The Compensation Committee of the Board of Directors of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;)
will periodically review the Base Salary for market adjustments. Any such adjustments may be made at the sole discretion of the Compensation
Committee. The Parties agree that the Base Salary compensates Employee for any services Employee may provide to Employer or to any Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Employee shall be eligible for discretionary annual awards of restricted shares of common stock equal to an amount of up to seventy-five
percent (75%) of Employee&rsquo;s Base Salary (determined based on the fair market value of the Company&rsquo;s common stock on the date
of grant). Any such grants will be subject to approval by the Board, the terms of the Company&rsquo;s long-term equity incentive plan,
and any vesting criteria determined by the Board applicable to each such grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Employee shall be eligible to receive a discretionary annual cash bonus of up to seventy five percent (75%) of Employee&rsquo;s Base
Salary based on the annual performance of both Employee and Employer (&ldquo;<B><I>Annual Bonus</I></B>&rdquo;). The payment of any Annual
Bonus will be subject to approval by the Board, and, if payable, will be paid in the next calendar year between January 1 and March 31
(inclusive) following the year to which such Annual Bonus relates, provided that Employee is employed on December 31st of the calendar
year to which the bonus relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Upon execution of this Agreement, the Board shall authorize a one-time grant of Company&rsquo;s restricted shares of common stock having
a value equal to <B>One Hundred Thousand and No/100 Dollars ($100,000.00)</B> (based on the closing price of the Company&rsquo;s common
stock on the Effective Date) to be issued to Employee within thirty (30) days of the Effective Date (&ldquo;<B><I>Grant</I></B>&rdquo;).
The Grant will vest as follows: (i) 50% on the first anniversary of the Effective Date; and (ii) 50% on the second anniversary of the
Effective Date, provided Employee remains employed by Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Compensation shall only be required, and Employee&rsquo;s entitlement to any of the compensation or benefits referenced in this <U>Exhibit
B</U> shall only be in effect during the Term, and any termination of Employee&rsquo;s employment or of this Agreement shall terminate
the Employer&rsquo;s obligation to compensate Employee in any manner or provide any of the compensation or benefits referenced in this
<U>Exhibit B</U> for any date after the termination of Employee&rsquo;s employment, unless otherwise required by applicable law or by
the applicable plan documents as they may be amended from time to time. All payments referenced in this <U>Exhibit B</U> are subject
to all required and/or authorized tax withholdings and deductions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Expenses</U></B>. During the Term of this Agreement, the Employer shall pay or reimburse Employee for all reasonable out-of-pocket
expenses, including airfare, rental cars, meals, hotel accommodations, professional dues, and similar items incurred in connection with
the Business (as defined in Section 7 of the Agreement) of Employer and in accordance with the travel and reimbursement policies of the
Employer, upon submission by Employee of an appropriate statement documenting such expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Employee Benefits</U></B>. During the Term of this Agreement, Employee shall be entitled to participate in all employee benefit
plans that are available to the other employees of the Employer, including any retirement plan, group life plan, health, or accident
insurance, or other employee benefit plans as determined by the Compensation Committee from time to time and as may be in effect and
exist from time to time. Employer reserves the right to adopt, amend, modify, or terminate any such benefit plan, policy, or program
at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Vacation</U></B>. During the Term of this Agreement, Employee shall be entitled to paid vacation equal to four (4) weeks per annum,
(accrued 6.67 hours per semi-monthly), such vacation to be subject to the then existing Employee Policy Manual of the Employer, which
policy manual may be amended from time to time (the &ldquo;<B><I>Employee Policy Manual</I></B>&rdquo;). Employee shall be required to
obtain approval from the Employer before scheduling any vacation and shall only be entitled to take up to a maximum of ten (10) consecutive
days at any one time with the prior approval of the Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Sanara
MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and
Strategy Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FORT
WORTH, TX / GlobeNewswire / April 5, 2024 / Sanara MedTech Inc</B>. Based in Fort Worth, Texas, Sanara MedTech Inc. (&ldquo;Sanara,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;) (NASDAQ: SMTI), a medical technology company focused
on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the
surgical, chronic wound and skincare markets, announced today the appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer
as Chief Corporate Development and Strategy Officer. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Zach
Fleming, Sanara&rsquo;s Chief Executive Officer, stated, &ldquo;Jake and Tyler are seasoned executives with a wealth of experience in
the medical device and wound care industries. We are excited for them to join the team and help us continue to build on the success we
have had so far offering solutions that can improve clinical outcomes and reduce healthcare expenditures.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Waldrop brings 20 years of experience leading cross functional teams through a multitude of business process transformations in the technology
and medical device industries. Most recently Mr. Waldrop held the position of Chief Financial Officer for Trilliant Surgical, and after
their sale to Enovis (formerly DJO) in early 2021, Jake held the position of Vice President of Finance and Integrations for the newly
founded Foot and Ankle division of Enovis. Mr. Waldrop&rsquo;s career began in public accounting with KPMG, after which Jake has held
Controller positions at 2 fast growing technology companies, The Planet and Alert Logic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Palmer brings extensive expertise in the healthcare sector, particularly in leading strategic growth and corporate development initiatives
aimed at enhancing financial and clinical outcomes for providers, while maximizing shareholder returns. In his most recent role, Mr.
Palmer served as the Senior Vice President of Corporate Development, Strategy, and Product at AQuity Solutions, a leading provider
of outsourced revenue cycle and clinical documentation solutions. Under his leadership, he crafted and executed a strategic vision that
included multiple successful acquisitions and technology investments. Prior to this, Mr. Palmer held various leadership roles in corporate
development, marketing, and business unit leadership across the Orthopedic, Surgical, and Wound Care sectors at Zimmer, BSN medical,
and Essity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Mr.
Waldrop&rsquo;s appointment is effective April 15, 2024 and Mr. Palmer&rsquo;s appointment was effective April 1, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">With
a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes and develops
surgical, wound and skincare products for use by physicians and clinicians in hospitals, clinics and all post-acute care settings and
offers wound care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the North
American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX&reg; Surgical Activated Collagen&reg;,
FORTIFY TRG&reg; Tissue Repair Graft and FORTIFY FLOWABLE&reg; Extracellular Matrix as well as a portfolio of advanced biologic products
focusing on ACTIGEN&trade; Verified Inductive Bone Matrix, ALLOCYTE&trade; Plus Advanced Viable Bone Matrix, BiFORM&reg; Bioactive Moldable
Matrix, TEXAGEN&reg; Amniotic Membrane Allograft, and BIASURGE&reg; Advanced Surgical Solution to the surgical market. In addition, the
following products are sold in the wound care market: BIAK&#332;S&reg; Antimicrobial Skin and Wound Cleanser, BIAK&#332;S&reg; Antimicrobial
Wound Gel, BIAK&#332;S&reg; Antimicrobial Skin and Wound Irrigation Solution and HYCOL&reg; Hydrolyzed Collagen. Sanara&rsquo;s pipeline
also contains potentially transformative product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization
and closure, necrotic tissue debridement and cell compatible substrates. The Company believes it has the ability to drive its pipeline
from concept to preclinical and clinical development while meeting quality and regulatory requirements. Sanara is constantly seeking
long-term strategic partnerships with a focus on products that improve outcomes at a lower overall cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;aims,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; contemplates,&rdquo; &ldquo;continue,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expect,&rdquo; &ldquo;forecast,&rdquo; &ldquo;guidance,&rdquo; &ldquo;intend,&rdquo;
&ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo; &ldquo;preliminary,&rdquo;
&ldquo;projects,&rdquo; &ldquo;seeks,&rdquo; &ldquo;should,&rdquo; &ldquo;targets,&rdquo; &ldquo;will&rdquo; or &ldquo;would,&rdquo;
or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, among
others, statements regarding the development of new products, the timing of commercialization of our products, the regulatory approval
process and expansion of the Company&rsquo;s business in telehealth and wound care. These items involve risks, contingencies and uncertainties
such as Sanara&rsquo;s ability to attract and retain key employees, the extent of product demand, market and customer acceptance, the
effect of economic conditions, competition, pricing, uncertainties associated with the development and process for obtaining regulatory
approval for new products, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed
in the Company&rsquo;s SEC filings, which could cause the Company&rsquo;s actual operating results, performance or business plans or
prospects to differ materially from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Callon
Nichols, Director of Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">713-826-0524</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>CNichols@sanaramedtech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>SOURCE:
Sanara MedTech Inc</B>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- .8# 2(  A$! Q$!_\0
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M(^,98D'-;/B/PQ9>)M .C7LDR6Y*'=$P#?+TY(-5[2"Y;="?9S?-?J-\%?\
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MMN]S&6! /S*O(P:FCLK^;6WN)-5L9KR*UD3R[>/:Q#?=SR>AJ'3BU=O5J_\
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?>)9!&XD3=_"PZ&IJ**DJRW"BBB@84444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>smti-20240405.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaWCabP9z5Z8GekhvWB4bdlafyYh+bahgywBHKLGkbwP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:SMTI="http://sanaramedtech.com/20240405" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20240405">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20240405_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20240405_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>smti-20240405_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>smti-20240405_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20240405.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm139953852150544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  05,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
    MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
                                            Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #E2858P?R .&@$  !.$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8;7.C-A#'W_=3:&BG<S>3Q @_IXYGB./T/'?)N<%M.NWTA0RRK3F0."'L
MY-MWA1UP4[R8%[8$[)^?5LNNQ&BG]+=LP[DA+TDLLQMG8TQZW6IEX88G++M2
M*9=P9:5TP@QT];J5I9JSJ#!*XI;GNKU6PH1TQJ/BW%R/1RHWL9!\KDF6)PG3
MK[<\5KL;ASIO)Y[$>F/LB=9XE+(U#[CY/9UKZ+5*E4@D7&9"2:+YZL;QZ?6M
MU[4&Q1U_"+[+CMK$#F6IU#?;F44WCFN)>,Q#8R48_&WYA,>Q50*.[P=1IWRF
M-3QNOZG?%X.'P2Q9QB<J?A:1V=PX X=$?,7RV#RIW2=^&% !&*HX*W[);G]O
MI^.0,,^,2@[&0) (N?]G+P=''!GTVB<,O(.!5W#O'U10WC'#QB.M=D3;NT'-
M-HJA%M8 )Z2=E<!HN"K SHPG:LOUJ&5 RIYHA0>SV[V9=\+,3_45<;L7Q'.]
MSG_-6T!08G@EAE?HM3$,\K>_S(R&B?JGCFBOT*E7L-%[G:4LY#<.A&?&]98[
MXY]_I#WW%X2O7?*U,?7QG0ISB$5#%J\IKX/#S0>7GQ&(3@G1055\((@*BON8
MK>LH</L5BS..<'1+CNYYSIAS+51$IC(B$'RU?L&5BC JXJ@ID'HE6P]5G$HC
MS"NY%S$GCWFRK ]N7,-UZ65[V.L/$)Y^R=,_A^>)KX4-;7#:(TMJ/87K!/ZC
M_^3_0.!XF-XMII-/9/8XN4((!R7AX!S""4RH9C&9R8B_D,_\M8X15W+AZ-..
MU^TA6,,2:W@.UH*]D%D$;&(E0E8D\M/3BBMVAY>>1X?#(19GU*T2IWL.X$R&
M2J=*%VP7)##P(A"ER43EX%#PJXIJI[M!??$G!GF4W>DYD'X404[,+MX:Y O<
M1[[*>C)<DD+!+^+PW". @B\,\;=<YECZH56QH&BNQT>UV*G:4>&202Y@WCH4
MC8VJ6E \W[\'G-@>!,5"[60M'"X'ZP]3N/P9&AN,L"HE%*\%[PG+N)UKM14R
MK(\,7!./V:JZ4+PHO$>;J\Q 8OI+I*=?)ERQWZ.NA[%5U87BI:&82!^6OZ=1
M<($/ ]K_B*%4A87B%>&+"L$K\XV26*5K$.EZD!3;KHL1586$XOG_60MCN 37
M)$DN#^DZJZ7"A9H6*K0J(A3/^8&*12B,D&OR  &N!8MK>7"5)AZO*AH>GM;G
MFE^&X!X.;]A^/0E+.ECY?EVMZN>O0:^1K*H4'I[6_T<VR[(<R!H!<=E&P*,=
M IZA%\+ FDZM"/4^+#^2@(<YQ%OM,J5!R<:GDD5"#8P*OUV0G]PK6/21E&FR
M93%:I;RJ"'AXUEYH%MG "UZ3I:H-NP:!X&$QPTBJ9._AB?G-5V3Z$FZ87/.3
MB] &H4<_N/-_PYBJ+.^=E>6G"==KZZ5?0<%L;.Y(F:R?55SP9*2UCG;']DO#
M [-/S$C,5R#D7O5!5^\W[_N.46FQ85XJ ]OOHKGA#-X">P-<7REEWCIV#UY^
M0AG_"U!+ P04    " #E2858GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX
M;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I
M=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[
MI#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4
M!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBA
MC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.
MB^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4
M?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&
M?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQ
MY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7
M^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJ
MOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[
M021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%
M^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%N
MXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"
M5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2
M='@//GL?)=-[*CG_5U/\!%!+ P04    " #E2858EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( .5)A5BJQ"(6,P$
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M'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #E2858)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ Y4F%6&60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" #E2858!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( .5)A5@$@41M[P   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .5)A5B97)PC
M$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ Y4F%6,'\@#AH!   3A$  !@              ("!#@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .5)A5B?H!OP
ML0(  .(,   -              "  :P,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ Y4F%6)>*NQS     $P(   L              ( !B \  %]R96QS
M+RYR96QS4$L! A0#%     @ Y4F%6*K$(A8S 0  (@(   \
M ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .5)A5@D'INBK0
M /@!   :              "  =$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( .5)A5AED'F2&0$  ,\#   3              "
M ;82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(    4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>smti-20240405.xsd</File>
    <File>smti-20240405_lab.xml</File>
    <File>smti-20240405_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20240405",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "smti-20240405.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20240405_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20240405_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://sanaramedtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-24-013261-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-013261-xbrl.zip
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M?)?LV5HJ(M"QA]@/5I4.E7 TC0@>ZGWO@88KLRN!YB3.OR'K#)>WIRPBC2W
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MEG%[L/L^VA:Q->2!G05LM0^%]8/K/\31QGH3W@['+B7=G6L)$:I%"M!E57/
M6-*JG1'$((0IXJ^Y#;^B0CG/<J9<\ 3QX=FX>9_ROJ[BCF_;#1'+0!\E>^_C
M?GN8LLU^0$:8=\I$.=F<"!;XZ*2:<G3FBE:]V;_J1TE6F<:"?ZUK1(X9[@&P
M.20#P?,M',0!PT'(DJ2\TF?U>#9@FT4 NI!.XC\PD/O#+I#[F0.Y/^P"N;M
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M]B(WZM'1ZZ>#3@[B..&)G7=D#<L)-$),*@:C_)81HE=<2-DYV!?/]L5!M00
M%]M>@@_B(?8E"U?=G/F9RK%SD];JT1 'E/@&2/9F8C98_PFM9#!S4I"&4]\R
M[QO0@%LV<X.AQQJI>@KC#4I1E"C%J79"F.^,T'&35!$A.1-9+TZ@P.B"&579
M)IBA_$KSM_C*<5WI[ 9\+V;W<=^A*(F>Y_JAVR258>#JV*89>X0%#-28=^I)
M4V;X+W7^L2#Q IWURZ&OB>&I0W4[@ 77#9WUMU/W+5!(Z,5I07Q=2W8%\YHW
M%%C=L1V!?7F&?-4L.>7XP8G&#PX7+ T>/CCXOI>!Y'+HYJ@*+K)D4>>0SH4X
M[!;Y18Z_DN(05%! -U,& !^QD' 8L7#IUBR7W1)Y"^(?2H '><*9T?8\?.Z2
MHY7:<69R3YBDD7!5!,>,7 C >!6D1E\'KZSH[2Z5$ZX6*%TC,/%R1.Y6N&O.
MDJKI.":"CM!AZB(7E#"VO5^1^/91HQTDO%G5S:T?'--RX<:PD8K"]/2RZ?(P
M4<[QE#C[4%1E_\"2F3+=@%Q)]N;YO/*H7?O52QV_NZ,I^@P6/=1!XSC7F*?(
M'17> BN9S=60AO+8)VJM\S;DP$%:-((KA:95NW/05%B7-!2^WY^*W'57/.I=
M/KU'K$<MP@M6I0RZR_WDD.XTT6M?[? =I-1\CK4--K1%1C#A<&9F(+M?I8KQ
M\H*8:YV\M;"/8 #_4;DE/^YR2SYS;LF/N]R276[))\PM.7C@DDM><4YWD*1Z
M*#I-SAD!ZOELI.\6W"4 1ETA=CCS@C7J91)$%JHZ:&TI)0_(*B]#S@Z#:KQK
MII9*^#(Q4C7D<3;?U0EJ'"(__ #BBF8%3 L ;.XZ^]7ACG8A"X@.?<E&G(BL
M6;NR413L[7VS'\1FTDT3!-!0 J8BC_V:I&#&\&'27(8LA89W\@RQ3]T6=8(8
ME+VA8XJZ:W22</;RO@/IE=>!L7!/ENQ ,](;&XI!E@'P2+87DY(F>S2MN]9F
MS\N*4#;T9<<'+S$2'5M%S%?,N )!<O,!1D3.5Y8-#M@XXYH%/'OPNYN/VY=J
M?JD?FYD<+V6:@2_O4>*.[^.NXF/.^R0MTSJ5R;TTV:DAT_*X7-P/I\Y"\Q.=
M_2<ZZ$]X%6_O1 _;MGRD<WOR\_].X3/;),\+@SPUR+7=H88PF':2\;[<WOD^
M/<^-<IDC#H7 !?X:>H&I=Z?[95[9@X</'LC43CI$+I)#.#1/.D3MOCWX=G>D
M7]Z1/N=X#:;V.\ /Z??F?=HD/WQ_\.#A^'FJ.;I33W?JZ9^GGIHO0CW]>_K.
MZ&5*BZRNUE\P1_STU_#VGN/_&?O?[BSO^EG>&<GVQ4S_$$$RX&TA[<#GD<\D
MOL:E,]QNVX/Y<T2>:\$1VE97F@3Q.-X.MWMKG:%:*1XT;9ZC,KTN\X:C4!$X
MAJW]X>G8N)I6&]!4%G4^EW+["W/'0DM?N&/\P#G&3X \& #_BW?\]W-3,B2A
MS4J:)8R'=D6&FO=H<T!R79LV@#6R)2B-Q02R91D"A\U0=%O %^>=PX2\T? !
MMO%<H_M7O;Z'IVAQY7D=;I:]C)(!CF,P#*>+E(7$HMV[&"D-?G[: 7\S(KBB
M?!GF:$XG =B238?5(=+6YS^NTIR7-3HE!6+3H/65,'Z[ZWF+KN=#=ST/&S!T
MG)"_G*<QX5N$BKGA-+2S7FKJ?1HXZN4<Y%/Y'@#KBBLGRLH"F1E.IG'70?#Y
M;&J!M+Y:=*NY9(ED>6-38J+?V"J/=;J1)&2;AA#70>>8/"@T0(7U31_LP\(I
M @@0!*20JE,;QL24Q4MC"2#L<Q%NV2S!WD)42-XP^?$ 7R\N<6E'D2W[58P\
M@:#<0BN2%GG*#73&ENR0(#7I+(!&FB5_VPK_=[?NZ-79&0</=ND9GSD]X^#!
M+C]CEY_Q*>7<-QY3+)=B""G7];+NI)O_84&!MP'*)0</;:+P-IUPKJ_G6C:I
ML&.@NBHL(76%<);GBX 9$9>0D(U%U.5,#%]%FD)?5)!/O(QD&-*/*WU 1;2'
M_7.%(7>+NW_AE/FMH\PWG-T=E"$X\FI&D&F"8F*NSDKK.M7JKJA.<]@8=]D5
MI%$@PS>$&C#U2A4?I'WGKBPD9:P S"RHN@Q:;]%XO6Z2"CR=JI("O!+7(,I^
MZ+IM*7XC' N,)R_12"0)C\#87+]XO-*FL4: LEP&Y*[K<%-<1FNH7RGN)6 5
M (039#@CYYYN)$PM3DPNQKMK95W+8"35O-"JC$8Q>5U3K3&\\KNJB'WA5_4[
M=U5_3Y'E%N3XE<!!MS7$<Q-U>EAU32M6OL4881K0&D17A2.N+9L:S[U1N0)*
M7@N4PZH3:T>16 7.=$<BMXE$OG<D\@N7A."P7Z27CTGUG>>MM!K<:E\[)8(Q
MW^M.L6H=<.UHL7ZFQ2>>D%!VX30,+9);:NC8^G<$"D7[!2Z+7$IR\&12=T50
M7%ZY4B%QP(;5CR2-X*JSA.LQ1VTA_W1BLT4EQ]5UIO*^7%\!SB4J8\ JN0+@
M!XC<TM?05U0TXKQS2$/BL8(]S*5C^M0?G38BS17IRK^ T4W8N] Q( 87"UI>
MC5)UVN(&FEJ A;#R<X?2=Y%G'8HR_JCR4@KT.%,5@Y4I(%1G:"V1,TJ3!:.(
MI)NZT6P5R$P!/OR7CE <ZY :I5*U4QR9@)SZ.M9A??MT8E'#W'H5A;EN==VS
MT)W82!<T(BZKVZ:>EJ.:$O96!-^]94JR13TK.HQ%6H:_F$X.25]=2%E0K[SR
M\/"P7UTI_1K"T<,;XVL:42.^=[SO?EEQJVG_8^EYB0HG/HQT.@&,DCHN&?_H
M4@O<>.*'AV$!<65Q8FT1MKBK^0YHBC3>AF4+\"MNL9M(PS.!'^>,3 $&FDJ8
MV>1IK7CC&)-=.<5&8 [$+EDQ@)S<$C8ETB9WFZL'R1OD,'Z,OYQNZ9+OC1NY
M=_!@7S*P4:O8UOD[V\]4X+^EXP<PR!M+KD96QCXO\<AYSS!';/C'>:DET30W
MZ<(4@.+=Z CI#:>BT:'C4=DBFYS9ESQ=I.59IYBU[;:W 8NB/ ,XB[+9B&B=
MZ]KWV> +$CC]H(SF0<Q)4&BD#%6W>Q;4%#LF(;6?QKQ3B!CFX*P7)H"'*PIN
MEL@5N:;@ZL;:E5$I#ISMNS #Q^)BPEYWD&6EL%5A!2V=>Y'_R]J>C$3(70I]
M 3 W0U4< !VQM\J9K8X+6T3$#1VUB@"]&[5S+/-7WROB1$I*M2F+8DB. VU4
M<UOF9KO$7(">T&2&&5[05(91_O7'3%[ATU*5('R^;8GL+696OG)8]USMJ6YB
M!KR;"2(58R/W=B5$L'!V-VZSJ;5$64P><\&\V6MOKOT(;Y_KG&/7!/8GU>BE
MW5OFX"C%*WM@#>U6HA5U<R"K(BK$UGNL/B$6DNYD^@E.0AWTE+#("3*I<%MZ
M?G9+FIM0P/B..>R&;Q8D)&8:A9I%=#N=K*H,1<A]P2?TQ87%<W^=T:&3Y(#%
M7)LEY]4E(H4SB 5KZ84\?A2^VY;2,GX !Q,@G[DZQ9*4V(:+P96WK>2NZ" 7
MLI]X!IB: ZU [. 2^M:: >(O(@@3[1>#Z[6B,^EJK\G1%;Y(23;0-K^)$*1H
MMAUC;O*SLP :2HWO$(P,*B +A[];_4>=4QN=E6A*VJJ&/_9+TO>Q<]=;TD*R
M"LX1JX2GJG1VHG8&C;EF"/54Z[4![ ];-3.B26TJE#FX2=)_2!J5B C)+;NL
MNB(+.D2 1GQH59 /;(>F6FPDQAWIB;[^,YO^[?*JH#K4D)T H:5M2>2&C#XS
M*++J/VXO4AKUVFX\!Y>->ZZ%[*$6A7+YO5-TW4A^=&I]7!CUM,K,OKU&M,Q-
MT)U7,.*8W;IP>>J[.X=@!-;CLH7K>&7?AZY3CVC/T*YJV:[1I<J66H,/ IWW
M/*T',KOJU67'0"U+]5X&$]J9N[?)W/W!AX_[[:B>F[ (\ECMMMRBDPB2C78V
MDSYS&J'D! <EU!%7?%]XQ'Q2$Y9Z3:[&&]O9?EK<%L%W6!IMK.55X# /J:I[
M'OP[1IW7!$X/=H'3SQTX/=@%3G>!TT_)X7TSIF=UNFRY^L_%HKAQZ5@D<P3(
M-O!& $J96ZH:1K&]$ >3)G66YJQJU2/$^"8Z[$A R$>12-NVX%]=801KSFL^
M@3<KS1LI&.\:&5)4S.O$C'L#.\_4-^N;_-7.;0\A)XO4C9@;[2):,GI2U*Z0
M%2$V$JR[]8[)CR^<]GW'D)==T>;KPH@_BG03.N+FRCPY[D;IO;0K^X)%\ )U
MT3D(UYX!*^J0=/667LIB@E@4_YF'GXW?$+2,Y7:K-C\ _03376CQ%I+:PP=1
M<QK$8Y@+';/9W01I*N*2D QA>/@:Z;+AL+-"'$J+>P<%-UTN4Z220#'F9I4"
M!);'>&V%@9-9T@":=5[GK7TOV*OV:DPS,"MK8IZ3_@ LYS79[ N0.$_<87P8
M8J0+LFX/.7!%?!SICD*S7&V,2Z!1\R;$W[2A]'V9#'9^;7C[@UXMC<164V[C
MJTVZ<RMP%)'8QK?8%\4].)GMKM=DNZ;:1E1R0J,?VRUI3+ RF8O;K5Q/9Y=A
M<YOOUBGBD [&19!&JU; ' M!&>;.$NS&(:ZI:1I,0S9TSQ1F,O&\BK.-?V2_
M%X@ZCQK#]?7#TGK682($=1L?)7HD]4-[!(+ \U(FXM+MM5VS&U*\W^AU;"W3
M+8-&/9E$80_ --UKTXT==U=!LV7ZH,S/0L)[*;'!M^8"$1Z!@"1ZE>#E5;T$
MJJYM<OBN[R>_E18UE"A&\(GY3<L8KQ"HC1&P(JO!*F%<PQ0:'][J957[Z,B9
M.-(S%Q+7'YVG]6J0DQ:@&.]H[;;1VIQH[= UYN;\CZ5%W)\C/,6D=I8O6PT\
M- VX#7LQP)+$+<>64:,XQ5J3(3JJ:L?>$@K4U8X4%NY(5K ?PS< L([_?"5A
M. Y2K>:($DO?JQZ)[<CJMI'58BM9X?QA'LG'2[)/"E;,@GQ3V]=#.1J0X%8A
MMG172E<G1RJ-X8=(48.NFN_"!K>.'K)](&E;>&_VH; .9&/*W/D$RH]YWP4)
M$! H=.57VOG1@0K/+!RX($9O:X,X4-49('D4>WA',K>-9 R3S(7V:D1>>56P
ML6C9@F!K2S]#,76UVV>CS6=61F62="#C+I?TO.\'[@U0W\X1B-/:4& FF6&:
MWR$XW#;7)!R<]#.$H9T@LQ%G6YQ,TF_A:F=]\R8;Q8[;&CX>38- %L0L[NPG
MJ?>(Q79K",0E5T2:&A&&9.^[O^Q+$@PWK5H@2 R0Z(PM(,E\AYN6N\PU@O@]
MW*'=I;AMEV))E^))5==BW;(QR*U--(NH\JRO?P?<Y=@=ZFT[U#-P.E5UBXWF
MJ?I^%R,*KT4MV-9YK]?">>EDK&_4K)V630#*KSE*OB&==JE@%QB7*(25+1)V
M<>8H?LB8\#OZNFWT=4[T]5LI"8&%-$OHQ(Y"IV9F%=*H.> 8VJB9<\+0F#FH
MF1K*"6G'UGCFLZ.!VT8#.=' 2^FTTRDIA'5]?+B^$;A^4!ONOR%->$$I=^Q<
MK\EX>;C+>/G<&2\/=QDO_RD9+Y^/-_Y!O/&HUTS,1E/%BZDMMC1I98X(J T'
M[J*!MS@:^- #DCU]_=NKDZ,703[3RS<O7O_SZ"@Y?/K_O'K]^XNC9[\<G22G
MOQZ>^J^.3Y*C_W7T]+=3XL')8?+BZ)?#%\FSUT]_>WE$,^3?/J6Y'AZ_.B%V
M_19_29[1KX].9LGK)R^.?SD\/7Y-WQV^>C:=O#TZ.7U[_%0_.4E.WAP]/7Y^
M?/0L^?7H[='QJV!*SW][>TH?OGS]]LKI_4IO>7)T]"HY?/:/XQ-ZT>OG[DO-
M9SU)WA[_\BO-]77R]@CSFTYD%;H?,\QMY+5'QYB O/WMT1N:.ZV81GCRSR1Z
M/GGS]OCU6[Q^,+#NW.M7O#Z:&OT.K\9R:#]?_)-NW8NCIWCKJ]<\PR='R<GK
M<+C=9;I-E^EA@.XGOJMO'_QXN#4QJM>]M(?@Q]E,[)+(T#O6%=BX^!%^H @J
MS<##;VL2M()'\J]6M#4N/JXU,=HNVH.Z8,J69W/"#>*9B+:6G>'2"GQY\./?
MOD?WS83TD9+]< XCS+4;;2192_S4MOHGY5C\69=+U7;>-)W4A]1& +OBLM=X
M'_O=15V-$2?O;'PJRI:U32=XSWU:%E(DN5R-?80>H&U;<T*/[\EU)"D<2FF=
M;%#QH=X#/1<]22Y,'84@@X?=1V9$?/J8'T+.N@,9JD2YCZ/V"BX;WE==O^\D
M9% I56H .]RQT9['MJG=H#,2=UQNS&68SB3)12C1C'M#HS;,QZ/&*B+I!9RZ
M5RW8DY))?#PHT(QP)<?267U?<-<!4K?85@^MD#W(QK6[!WQ-@A"J[B5PZE!V
M(TV19&?5U]O;5BD[OGI?I6(,T3F?1]/?G@'X2;!?&I]CKWGXF.TGZDB@01?X
M-&ALRB6L"W-S$L =G(WN?1^U<EA+XLJ4&^GWJ9,*9CQSFS;\+J81.V,X8U%;
MS0 [2CB8^G#%R0<OV%[O?C/=<#\LGFIJ3V+DA@90[E$/;.[R3E>I*(0^E1'O
M]\O=II,TT74XFKV?_-YS&*2<.\6E8?1QOIHC[!$0OLEZ: +1'-&-3-,>I;C,
MD*CC-M;2(S1XWW3B(5?T+DKUMD,ZBH]J)HW*."^0;Y@@$5T[CGTK6P<1AT0C
M6^ZGB;Q+7OX'O]NV,&9A$KV=IZOSC9X1I&7W\B7C'A"WM;VMI8%O6 (U#]X0
M8,@R+Y<+KX <D@)*FYJEOJURM&3/&8;?V3Q[J4,."C$M.;!B($<UTS;H%_M!
M%2_<3985]C?*2]( G[3(_QL2MY5D?_-^<9Z69\J3N?EKI5H"<]%1L1&PBF$?
M]JM%1[[$[@T8XE9>,8M/*"H2\*R1[I%P<^->?%.F. L%=BP_D' C]<#A_,),
MQ2T<W39?9J2&LP!7Z^/)=@]-S)Q]S^:6C8.[^NNR+E(&0*C.ZG0UP[KKBA$[
M$&"5$D-F1JC/WR1G0)K8U^0U*"<9M\L."]=%DFZ"YK:B7++2)Q^>UER\O2'-
MT>J#B>TP?G ?\[]W$#+7,3P$SM(GK;&]QTS*[9D;S"/3^CZ0/<C;F\QC;[Z_
M]^,^<Y&]0/[0FWCK_'C[LY#5%^E&U/3IA!LF"JJ$<.Y0A$BWZ&ZU)I&[\J=&
M_]EH,;<H2D%BE^'177%V@EA$8?AY5DQ#.=2HUX4V8]X83>%FX<Y3W$\$?(CD
M7HWP)K[=>R_<!!S!.W":_'VR]_U^LJ*+>R[F!4/''# PBB(0#1&,8X%-=H=(
M;)>D)+6D2HIT(X!^E *5AQG;)IC)*&2<_VT/5'O<#'*%28,C&8&+X@(KA 4+
MQT\SKB#WS&5I.] '#->RR<]JO'Y<T_4.6N-/4)=/ X)8YH:$<0"8.*S'B] /
M%1>%@3M2%<$6T*M?\"&*; \HTF,8"B/OVUI!9LTX%(SFO4?!8P77MD$H6Q$(
MTP9QDH4^'!F_,\4]5;-I.D&23JGX$SIIAW?F/+8PSTD7*^]</.O?G_[V&!9_
M-AK/^6AK$5_(_WO"+H@."5<<"GG..F;S_UG'R*<ZJX^_%'LXH_.^)NCXS2[H
M^+F#CM_L@HY?U(WZL@4Y+1!1F=^/3U\=G9PDOTNP!,N,.T5HB3DKTZ[8N%\B
M[S$"4Y&H8JUS*W7&,K<U:'=-\MWM#I*C6SK:G.[I:VS J__ZZN%75SPLVWJ3
M&7YD2C_]]4@;$4NT\"WH/&XH^2D;^EVY)7K6WSWXRY:]_1C[Z8?YRY_< _#C
M3/O;3SWOSW3\7^!U.CE\=?CV4.;Z\NC9Z='37Y/C5T_OW][=O&T[^*EOS7_2
M3;EM^_5D\T@G=]7Q7F<G;=$(/XOT//[YZ^9KO>[YXCPU1?+L?O)R\<KD12*J
M\8XX;K:7;/+=@#QNS83UP&6"X:GO3OR&N""(@GY11\X 'S*]YZXZT:)\W/&N
MR3MK[O:KGV3-V91/-N)N 2_:V7 [&^[VBZ([K9G^/7UGDM_3(JNK]4XIO=M*
M*<Y:9N</_"ZK)==$[K[=1>X^=^3NV__XR-UP*S]$0;A!,L M3F*XDDE\FK2%
MWWX^>G^>S]&.R!7"?*GK^>)/X_GKMR^GD]?/D[='+XX.3XYVAW&K MV'S71B
M@=@Y;OV+-,5+WIK"I(V9^81]32.67E<V:5B2'[7%&*,*V_Z%KL'NS#8'YGYJ
M@O2*OW&R;,OP!PT:,RXT1:SI<L:] &A[XS&9HA:^J(Z:<ZK96*N0&6===CRV
M[3A)?RVJQK;$*7(25D6NK8&!W9VV3050I^F$)L19G)+WQ+W&BO1R9G.50SS$
MNQ:P_Z))^7E56Z1J3H '[FKJ452#*L;, *1N+E3OQ47R!-(BAO6)NX!+_J*D
M%9_9;F07I%]RVG0T*%'TINIFFI*,M.9D;NBR+#&;#>.-%4O)!J%_2)?Y6=SE
MLIEI3@G_U3>4Q^=<TX*R1I]=<N0^>X;,YKT4"UTB(W0ZD0)-R4G=GR&]7F!G
M\%*H1VC"4]L;7QO<4&G]D#>+<SIA7TH_8U 9J5),%!=<_K%.:[EG "G-LSRM
M<[UMJ4/T UQ:=2;)Z#8=.J]MB1*W97.@Y [-;<:]/4N!P$$+*X#.\;]6!CTP
M\9>T),TKAC*7#%H^\#WHUT;[7<PD<SVJ^?REKKIUO]A3JL&XP$)1_K7/GZ2O
MT[DEYTC51=$+9P#QOQAU]U(^L#TI JC#H$9"9N\:BO$<A&"0\.VSV(5>PM(/
MK4WL5;/T?\4;')R;*WQ H][2-MQ4!%A>&<\%:K/T1+ P[\3!ZZH\ SQ-6(A'
M'!Q7&T1"!-.@'0(17+K2;PNZ88P:V11I*>TBZZ!H92F-UF:V/W)-_)G,&?#:
MZ213G&5>0@]3<IYR Y$2ATO$FB[HOXUY/TOD>T:J1'N&&9T!T>8B7<^X^^,9
MSXI>)JR?.;E"6\;=4?/&W@7>#SUTE7&-]#E6\ F_@[.00&R385^L<DA7Z%F\
MCKR,> RV67K,_>/XV-[II_E%7DPG;Z4I)O^F#3KY*B30,[LF7#CW(WXV\8]*
M#?6/!_+M$7>$>T.DRP^X/A9,F;VS88F)PYE.BG2N# T"_5[_;-"^>N9:[\D'
MKI!"*X-0)<E([=S]49H6\G&6#OC,E6*XVC-+=T8N;W@7E@'$5?)/NI1:24'S
M+3;V),/3^;!32?;PR[@Q\K.C067X=!*V+.U?16:4;51_MM,=;I'N0&2# ^2&
MO;:(3O@[-Q)MN6>LU/:XJB\I#I0O+*,/^+AO2"ZE_;$(XH)5EJRL*A.ET NX
M+A!W[))U8,=&4*EQ'7]W8 BA4-">1E;-<#JYKR[Q2T7!K%LJST.6&J\3'03=
M]*394DM;F[BFUP.0,JZHBSMHV[KOGJTAQ2%R1_7:HLZM7Y#<?VKOFKH6UQXW
M[BI\O0#=#[JZ3B<*FEX:P*T#WC%HF#@ZKZJV?:@9;;8W%H8GS9'TI-:5\TI+
M5C<3;84<L"OB._>GDU>5Q5,8'SCLYZV-LA@LKA(M%X?-FLU2^MJF2HAR<HP6
M#\]BOI:MTBIH0=JUK2.9/'SOU:CWNY<N 2-]O0;31^]=QBJ$OC!L.']T]/KI
M0 GC+M0,D%NSEAVK"Z3QDXJWV SKA[5_DSFKF#*P:J7X2C8ZV.2P%R5)+8'O
MM&V!+?@4;U)P65F?T<LPG<C]H.5C(-'?Z"D4,Z)*&?*-AQ,;X'YRY-H%^QK,
ML&Q0NC[0DL_J='T^BV_H1560<4O<H=@$AV488 -3=3W+@R-2! 8Q:AG(E(V@
MM=1T!;W31"M-0J54F(3NPV7J.L9)%R0B-F/Q1]F>((VQ45AD83JNWE2;OUTW
M7)@QW_(Y);![1JE])T9OEQ@EQA!>*6/;/9W QN0RV#?6#/?X01]HAC.&@O3>
M*C:^!I(HB\OH-SP+,9T%20#P*P5XZPAL[\P6OA,/^C_\/[ ?U&HX*@QD;LC%
M09RS[9),%-7WZSSV0I"Q38Q+JKUI0E46N"/43+=2C!$#:(-"K)3^2-H!G.NW
M\>IWNX8NM^U*$%,FEAM9)2R)>HJ(;WII;1;;N=+I>"@4YD<SQ>-@W@B)M0D\
M4QZ8J I<%9>,FA^A*G@@$CR,ESL1Q/7G-W)T@5O[VG7M];%URO)^K4W>.G'7
MLE,UH33$R4FYA0F94]S^LR.92(R$5N%@FH S49%^P5,5Q8^WB=F2X![4B?AZ
MSVVI=7]$Y1[;+][NDMVB2W8(/!FY0XMTG:,ER;\\.[7N+D_WZA?MM_NTL"?H
M45CJU5Q9@-$Q0;0C@EM$!,)I/<I"SXH'K,*X" 6V22NH3+5!+R/QC;/=Q>8$
M?VV)@TWGVI9[BJ4Q?.ET$BKIS.*4LZ Y"#HLB3K/-A<S,3]OP") /0*0! 0&
MNR7AV H7QU@Y$E?K+?0\%4= Y4TN>-T=UV8/LU-VDCWZS[Y7>6)\B9&.S..J
M3C@!UD72[()U_;F#.JS=++JBM<CU+H ','.QF*_>6-D)&.-:;SL^*_<VA85:
M%)U"S@D"EEN_WX,$FX 275'+1"[D?&IDPZDW(R.+OE)K<BNI93#[FBJTT]0S
MZ?B-S"+0E*&YC2^%(TA65^1V3.!.>S_LRX%YU*^;":X9CH0X'+O7I>Z8U8(\
M0/$)=%2/*E2/P=E8=*B#!S'F<H]/BE=]W%$A>&%D5AO;91DV VU<7HCVC4TZ
M3_;^]M/);V]^;L]_^AI_"D#058O_L]%R/G>JVW>[5+?/G>KVW2[5;9?J]IE2
MW9Y\Z:ENM!Y[(%_T(IZ^?OGFZ-4)H\Q/)T!R?W+TZNCY\>G)%[ZP/_MT_B2[
M(6A'$*!B>@3UP\8!\5E0:,4;;!R *TR%2-DU 2AJ@'Q[JLBW,43,H[NEI]R!
M[B/HP.Q.TL730MQ>Z]N&"5.6B';-6:5-"VG]QL=]5E=-$Z . VSE'+;?KT09
M()CG^;*%M71Z7G6-Y$EDR:OJ:]*)DF=0E.IF.MG[G]\<?#=[\.#!_0</Q%)C
M*.\ Q+=-WVO"DSC2$) 1VU+[<S8C60Q/,-\3GN\0YCZ$ G4JO^"41]YSC\D)
M0SFMLP'4*W1_DX172P* 9'@8:S,\J? D_>.9S?ER"3#:&7-D^GAFF(7!5K48
M2RX#Y"*GD^=Q_)+Y+DL;-;)505<<E*#K;G'*@T]MQVQ&9=:>"*0-&TE_,:%[
M/USH=.)6*KM@8:."T'M_6@Z9EW[F*-#BFCJ^$[4;5:=J9*J)\8MG=NUT;R^;
M68RSF1"2W%,8J$-937I)M,]WQ.90B3.S-MH"DG.OFK8BV\UP*)Z)(>!$TIZ6
M70GMYA[:U'*^A_2I_4$;U0Z0<4-"W;,I#9![-B6/@^YI[FX60@:F=Y?=VZ)I
MZL.(J7'6G4!"!]>1/VC$:S;W*258&'>M!@?>>&XR"SQ96\8OJO),8)XUM3LO
ML7YNV0OX:LDFQAVR#8\7=4Z_SWTZA\]X$!86\N1*8/_]Y'?W[[;=O^SJ^Q>*
M^?&+N$B;\V1>E5TSN%2]WL]7WJGI1"]5=)%T#'H%]Y%5F&VRA<\#5&&B4,?T
MXVR:0WG\"6;7EY,BCGJ]3>0!]#+&>FY^T;C=1[ZT.L/,/<IXV*H*E722O9X$
M<]->0OGY>TKCTN(/>#4OTYHNS#<'I/?DXK:],/N]W@;\N(MN\@T+5RMY7EIM
MHN#H$>!R[MJB\F8_HT/F+)1O#GSO.#O7Z20>#=_-PU$^V;7>W>#K;S :TO^&
MI(^AWSNHVO ,6BZY=H;Z%^YU59I[G,+(/!I/]^7$]3)6DC#0@T4$GI.Y=!-?
MEU[=OT+-3_;^)_TKTO+W(FY@NTYST]>K1>IT$LG4N#!DW_;]TC980=< UP$B
MKXE_[7WS8#]*@^D7F/0J*&CW!FQF.CGEK*Z4TU5IYR%)D3$@][EYQ$UEOGOP
M%Z<\""IJ62);A],L1P=_K"U*XH<;@UR@D:>)RT>/!XS!+5Y@_@/&,-_8[=W=
M\,]XPY?[;$9YZU&N<%46&_&],/*\ANN&_5+$9'>Y(Z7OG1.^,VS'XFI!?"+F
MP,_:FP3]3B)7?5^/[R+Q :VZJGK(PW1 5P8A\<.!%>Y+)+FHQ]F2<6<0I%W2
M)1$ST5J/_][6$(GU$_>LL<JYFY(3/I)K?<4&S&RS,I^P84^9TVJ]CHWJ$LZU
M';0UXB8J6;7HM&%'([U/U([7#H+:F!#,'Y%B^I/LC:+PA8)7DH(NEW.[1$?B
M #>.R4V73O_KJO;R)H.K)G;,2'8BTJ<19M_9"+?(,^Q[:QYI1R_O%7YVG5-W
M%OG)]/XB92]LG]5S\3#IH.B/:;CJVGO5\MZ:1+EI.964YQ!6\I&IO4QKKMDL
M6[9'I"PR+>B/\ZHU!;OO2"G(4BV<ION^-)Q]3[_/.J.EI4U.>X1&8:U9^59@
M6DM;:I0?A"M7[0GIY27N:%!FBA_;?( ?+"]Q^Q%:/[56CHYVQVGK] +S+K-^
MCSKN.&(:+]1="B_G_=(MM'4%H2.>K1NQ74AW E/B$@)IO:,< GO)9H3=Y)W(
M_SQ7[AM_Y>SY/5'I\T%W[VKG?5PTP??.UA!:83>=0(1HIQ[P^/0BI0NB;@'.
MKV)7NZ\W[O4<CZXIMY%JM4..-D<[XUJ'(E^JNRDYIVN+QE/@!(L%M^%!\YRF
MX[SYF4,>&,PUD:GR3>S[I;8XW@>23^O+K83T&@TW&S/O\Z8=$Y?N0J-RKK8E
M(2ZO*<VJ-:I+(6^)+U49D1 OQ-=SNKZ@X6)F<MGEM]I%CLPK7W"VDY.WZ-)^
MZR[M/])%+WKZ$>YJCM1S34=SEO42^5Y[W^XGE\:\:^ D8W_9:C:=[-'MX:JW
M[^]__P-)01(@_#V)D?P>=YHK-FBK!Z)S+Q:C.'!VL2@Z-_ LY.+]=?-\P[29
MO$S9Y32X]]IH4R@8FC9^=9WF.1+A&A]OZ,H;[I_3/]MJ.JGFZ OFG7>N&[>[
MN]IAM%F<DQY:6(;EMH;5@\C>"<^G!;B@>#Y36N7[?-7)*2-)\>#!/F=\LF\&
M,0;V)^@]1I8D+]V)?LG:=#.U3@Z [B9'[_4E%F_WRQ71UR3R??\X>2V-+1\E
M+]#Q=9?-]UFR^;[_4[/YOJ@&4.-"[.LGKY_]$Y"27_]Z^O+%S_\_4$L#!!0
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M[4]=_=^_\_;('U)N38-.8?7E;SSSOC/@HX2JF=DVV9DWK:_'\%\,_3I-JT,
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M8G_X (80SC?S)6>HF%)5TZ<(@##C#Z)6+E($92!4)=3S1BO ;B/M-959G+^
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ML"S!I Q_?.0.*V?; '[SMW_+5H=['_O?90-D=)A<__=R]7*E5$HD[]W_3SL
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M3+'9DE@/0+\2=O*4AJ'6NX$?>1 F#62TMV-LI1.CYY$$KL54HVCMPX_0G,?
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M0VS5(W*I]M/D(?E(I;^)N-T=<5N;Q/@L+VNGZUIC4/N=@3^TZ_\/4$L#!!0
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M>]PJ"J+WNYR9))1:U!0[QF+!:1(E6<+6O\B33Y%@6ZML(E= P 8U#6U%$"B
MMDP.#D*DE8XAN!-$04AD1^0O :K$0N+VX<$ZVW>)74'1;UC# 2N#@*37G@F+
M#!A'M0A4A* \QB\V\S3=$O$F>"PAGA "S0,@M?0AX@29[(6J"/3)UH)$6SD_
M[D^FJV624=O)95OB;$X"S%4SDE$>!!N *9.%O SQ!W0R_>OJ;TA'.>[^&[X4
M6"6/7>PW*TZ![%-6E2L(.BQJ#BR2(%" ?9DTW'!42E&A]9&=JF'6TARCW!4
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M+FAT;5!+ 0(4 Q0    ( .9)A5CSMR]CUAH  '[3   +              "
M 2YF  !F;W)M."UK+FAT;5!+ 0(4 Q0    ( .9)A5AB F/@+@,  /(+   1
M              "  2V!  !S;71I+3(P,C0P-# U+GAS9%!+ 0(4 Q0    (
M .9)A5C)U'6G_0H  ("&   5              "  8J$  !S;71I+3(P,C0P
M-# U7VQA8BYX;6Q02P$"% ,4    " #F2858O)1-LEH'  #?5P  %0
M        @ &ZCP  <VUT:2TR,#(T,#0P-5]P<F4N>&UL4$L%!@     &  8
*;@$  $>7      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20240405.xsd" xlink:type="simple"/>
    <context id="AsOf2024-04-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2024-04-05</startDate>
            <endDate>2024-04-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-04-05" id="ixv-469">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-04-05" id="ixv-470">0000714256</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-04-05" id="ixv-490">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-04-05" id="ixv-491">2024-04-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-04-05" id="ixv-492">SANARA     MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-04-05" id="ixv-493">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-04-05" id="ixv-494">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-04-05" id="ixv-495">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-04-05" id="ixv-496">1200                                             Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-04-05" id="ixv-497">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-04-05" id="ixv-498">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-04-05" id="ixv-499">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-04-05" id="ixv-500">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-04-05" id="ixv-501">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-04-05" id="ixv-502">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-04-05" id="ixv-503">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-04-05" id="ixv-504">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-04-05" id="ixv-505">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-04-05" id="ixv-506">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-04-05" id="ixv-507">Common     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-04-05" id="ixv-508">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-04-05" id="ixv-509">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-04-05" id="ixv-510">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
